preliminary programme - fip...beijing 102211 china tel.: (+86) 10 61782288 fax:fax: (+86) 10...

HEADING

Preliminary Programme

Main Theme: ‘From Anecdote to Evidence: Pharmacists Helping Patients Make the Best Use of Medicines’

Beijing, China, 31 August - 6 September 2007

Your Hosts:International Pharmaceutical Federation (FIP)

together with theChinese Pharmaceutical Association (CPA)

HEADING

Welcome to Beijing!There are of course numerous good reasons to welcome you to Beijing!Welcome to Beijing!There are of course numerous good reasons to welcome you to Beijing!Welcome to Beijing!In this international city, the ancient and the old blend attractively and vitally with the new future; Beijing annually attracts over two and a half million global business and leisure travelers, most of whom concentrate their activities within the city’s oldest and most historic areas. Founded in the 13th century, the Inner City is today bereft of its 40-foot-high ancient walls but still identifiable by its canals and maze of streets where jade, ceramic art, enamelwork, paper and writing implement makers and marketplaces flourish. The City Center contains what most Chinese consider the heart of their nation: Tian’anmen Square, and the monumental structures centered on it; the Great Hall of the People, the Museum of Chinese Tian’anmen Square, and the monumental structures centered on it; the Great Hall of the People, the Museum of Chinese History, the Museum of the Chinese People’s Revolution and the Mao Tse-tung Memorial Hall, the resting place of one of China’s modern-day leaders. Most spectacular of all is China’s ‘nested’ city, the 15th century Ming Dynasty Imperial Palace, whose two miles of walls enclose the Imperial City, the north-south aligned series of palaces where emperors ruled facing south, with their backs to the Polaris, the North Star.

Welcome to our congress!However, there are also some excellent reasons for you to attend this particular Congress!Welcome to our congress!However, there are also some excellent reasons for you to attend this particular Congress!Welcome to our congress!You can learn from and exchange information with your professional or scientific peers, and listen to world quality experts in the fields of pharmacy and pharmaceutical sciences. You can make sure that your country is represented, or, make sure that you are not the only member from your country NOT to be there…! If you are from Asia, this is a unique opportunity now that the FIP Congress is held in your region, and for those of you who are from Europe: next year FIP will be in Basel, so if you come to Beijing you will support your region’s promotional efforts…! And for those of you who are from (Latin) America, and attended last year’s Congress in Brazil: Keep up your momentum of learning!As you can see, there is a perfectly good reason for everyone to be there, so we are counting on welcoming you in Beijing!

Sang Guowei Kamal MidhaPresident PresidentChinese Pharmaceutical Association (CPA) International Pharmaceutical Federation (FIP)

2 WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

Sang Guowei PresidentChinese Pharmaceutical Association (CPA)

HEADINGPRELIMINARY CONGRESS PROGRAMME

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES 200767th International Congress of FIP

31 August – 6 September 2007, Beijing, China

MAIN THEME: FROM ANECDOTE TO EVIDENCE: PHARMACISTS HELPING PATIENTS MAKE THE BEST USE OF MEDICINES

67th INTERNATIONAL CONGRESS OF FIP 3

Your HostsThe International Pharmaceutical Federation (FIP)together with:The Chinese Pharmaceutical Association (CPA)

Venue and Headquarters HotelJiuhua Spa & Resort, Beijing, China

AccreditationThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

YOUR HOSTSInternational Pharmaceutical Federation (FIP)Bureau MembersKamal Midha PresidentJean Parrot Immediate Past PresidentTon Hoek General SecretaryPhilip Schneider Chairman, Board of Pharmaceutical PracticeHenri Manasse Professional SecretaryDaan Crommelin Chairman, Board of Pharmaceutical SciencesVinod Shah Scientific SecretaryJohn Bell Vice PresidentMichel Buchmann Vice President Bente Frøkjær Vice PresidentMitsuru Hashida Vice President Mario Rocci Vice President Malcolm Rowland Vice PresidentPrafull Sheth Vice PresidentLinda Stone Vice PresidentDick Tromp Vice President

Chinese Host Committee (CHC)Chinese Pharmaceutical Association (CPA) Shao Mingli Honorary President Sang Guowei PresidentZhou Haijun CounselorZhang Lihe Vice PresidentYao Xinsheng Vice PresidentYuan Tianxi Executive Vice PresidentLi Dakui Executive Vice PresidentBoard Members of CPA Member (43) Li Shaoli General Secretary Hu Yin Vice Secretary Zhang Xiaodong Vice Secretary Tian Songjiu Vice Secretary

Programme Subcommittee of CHC Zhang Lihe ChairTian Songjiu Co-Chair Liu Chunguang SecretaryWang Aiguo Secretary Zhu Zhu Section Coordinator Chen Zhengyu Section Coordinator Yue Weimin Section Coordinator Zou Zhongmei Section Coordinator Li Yimin Section Coordinator Han Feng Project CoordinatorLiang Yi Project CoordinatorZhou Yingyu Project Coordinator

YOUR HOSTS

� WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

Venue and Headquarters HotelJiuhua Spa & ResortChang Ping Xiao Tang MountainBeijing 102211ChinaTel.: (+86) 10 61782288Fax: (+86) 10 61782246Website: www.jiuhua.com.cn

Official Housing AgentChina Commercial International Travel Service (CCITS)45 Fuxingmennei Street Beijing 100801 China Tel: (+86) 10 51656540 / 66062448 Fax: (+86) 10 66095637 E-mail: [email protected] [email protected]

Tours & Social Events (Section Dinners)

East West Executive Travellers Pte Ltd5, Temasek Boulevard#12-05, Suntec Tower 5Singapore 038985Tel.: (+65) 6238 8488Fax: (+65) 6238 8878E-mail: [email protected]: www.ewet.com

Congress InformationFIP Congresses & ConferencesP.O. Box 84200NL-2508 AE The HagueThe NetherlandsTel.: (+31) (0)70 302 1982Fax: (+31) (0)70 302 1998E-mail: [email protected]: www.fip.org/beijing2007

Congress Registration & Abstract Handling

NewBrooklyn P.O. Box 73 3620 AB Breukelen The Netherlands Tel.: (+31) (0)346 266 110 Fax: (+31) (0)346 263 308 E-mail: [email protected] Website: www.newbrooklyn.nl

Chinese RegistrationAll Chinese registrations will be handled by theChinese Pharmaceutical Association (CPA)Tel.: (+86) 10 58699271Fax: (+86) 10 58699272E-mail: [email protected]

FIP BPP Programme CommitteeMartin Schulz ChairRobert DeChristoforo MemberBente Frøkjær MemberHan de Gier MemberTon Hoek MemberHenri Manasse MemberLindsay McClure MemberEma Paulino MemberPhilip Schneider Member

FIP BPS Programme CommitteeVinod Shah ChairDaan Crommelin Co-Chair Dirk Maarten Barends MemberGavin Brooks MemberCynthia Brown MemberClyde Cole MemberHorst-Dieter Friedel MemberHideyoshi Harashima MemberToshio Honda MemberBert Leufkens MemberAnke-Hilse Maitland-van der Zee MemberJames Polli MemberHitoshi Sasaki MemberEduardo Savio MemberCarmen Tamayo MemberBrenda Waning Member

CONGRESS ORGANISATION

TABLE OF CONTENTS

67th INTERNATIONAL CONGRESS OF FIP �

Page

INTRODUCTION OF FIP 6

ACCREDITATION FOR CONTINUING EDUCATION 7

GENERAL EVENTS 8

SOCIAL EVENTS 8

SESSIONS PROGRAMME PER DAY, PER SESSION ROOM: 9

FRIDAY 31 AUGUST & SATURDAY 1 SEPTEMBER 2007 10

SATURDAY 1 SEPTEMBER 2007 11

SATURDAY 1 & SUNDAY 2 SEPTEMBER 2007 11

MONDAY 3 SEPTEMBER 2007 12

TUESDAY 4 SEPTEMBER 2007 16

WEDNESDAY 5 SEPTEMBER 2007 20

THURSDAY 6 SEPTEMBER 2007 23

ADDITIONAL PROGRAMME ITEMS 26

CALL FOR ABSTRACTS 27

GENERAL INFORMATION 28

VISA APPLICATION 29

HOW TO REGISTER 30


INTRODUCTION OF FIP

FIP Congress Structure

FIP (The International Pharmaceutical Federation) is the global federation of national organisationsof pharmacists and pharmaceutical scientists dedicated to improving the access to and value

of appropriate medicine use worldwide, and contributing to changes in science,practice and health policies worldwide.

The Bureau is FIP’sgoverning board and iscomposed of15 elected officers.

The Council is FIP’s highestorgan, and is composed of

representatives from allMember Organisations.

Council

Bureau

Board ofPharmaceutical Practice

Board ofPharmaceutical Sciences

The Board of PharmaceuticalSciences (BPS), representing

the Pharmaceutical Scientists,prepares the PharmaceuticalSciences programme for the

FIP Congress.

The Board of PharmaceuticalPractice (BPP), representingthe Pharmacists, preparesthe Pharmaceutical Practiceprogramme for theFIP Congress.

SectionsYPGSpecial InterestGroups

The 8 BPS Special InterestGroups (SIG) have preparedtheir own congressprogrammes discussing theirrespective scientific interests.

The Young PharmacistsGroup of FIP prepares acongress programmetargeting the youngpharmacists, scientistsand students.

The 9 BPP Sectionshave prepared theirown congress pro-grammes focussingon their respectivepractice areas.


ACCREDITATION FOR CONTINUING EDUCATIONUSAThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The sessions identified in the programme with an * and a programme number are

cosponsored by ASHP and will be available for continuing education credit for the number of hours indicated. Pharmacists seeking CE credit hours must either complete a CE Request Form online and print their CE Statements or complete the CE Request Paper Form on-site. ASHP will mail validated Statements of Continuing Pharmacy Education to them within six to ten weeks after the Congress. Instructions to process CE online will be provided in the Final Programme booklet.

Costa RicaActividad válida para Recertificación Profesional Farmacéutica.The congress sessions accredited by ACPE are automatically accredited in Costa Rica. Costa Rican pharmacists are advised to

acquire a Statement of Continuing Education Credit according to the instructions that will be published in the Final Congress Programme booklet, and to present this together with their certificate of attendance and a copy of the congress programme in order to obtain the credits.

GermanyThe congress sessions accredited by ACPE are automatically accredited in Germany, as agreed

with the BAK (Bundesapothekerkammer - Federal Chamber of Pharmacists, number BAK 2005/33). The German participants are advised to acquire a Statement of Continuing Education Credit according to the instructions that will be published in the Final Congress Programme booklet.

FIP has submitted applications for accreditation to several other countries; a complete list will be published on our website www.fip.org/beijing2007 and in the Final Programme booklet.

Would you like to help your colleagues from developing countries?

Become a Supporter of the FIP Foundation for Education and ResearchWith FIP Foundation support:

…..young pharmacists from around the world are able to travel abroad, complete their education and/or pursue their innovative ideas to progress pharmacy.

….. pharmacists and pharmaceutical scientists from developing countries are able to progress pharmacy significantly in their communities.

….. new and innovative projects for the future of pharmacy are supported and developed throughout the world.

….. pharmacists and pharmaceutical scientists, who contribute to the international pharmacy developments, are recognised for their efforts through prestigious awards.

Visiting address: Mailing address:Andries Bickerweg �, 2�17 JP The Hague P.O. Box 8�200, 2�08 AE The Hague, The Netherlands

Tel.: +31 70 302 1970, e-mail: [email protected]: +31 70 302 1999 eb site: http://www.fip.org/foundation

The FIP Foundation for Education and Research is a non-profit organisation and has been established under the auspices of The International Pharmaceutical Federation (FIP).

FIP’s mission is to represent and serve pharmacy and pharmaceutical sciences world wide.

Attention!Please check our website regularly for

programme updates:

www.fip.org/beijing2007

RegistrationThe registration desk will be open:Friday 31 August 2007: 08:00 - 09:30, ONLY forparticipants attending one of the Pre-satellite meetingsSaturday 1 September to Thursday 6 September 2007: 08:30 - 17:30

Council Meetings(simultaneous translation)Saturday 1 September 2007: 09:00 - 17:00Thursday 6 September 2007: 14:00 - 16:00Only official representatives from our Member Organisations can be admitted to the Council Meetings. This means that each representative will be asked to submit a written proof when registering, that he/she has been officially appointed to represent his/her organisation.

Opening CeremonySunday 2 September 2007: 15:00 - 17:00The Opening Ceremony will take place in the Great People’s Hall on Tian’anmen Square, and is open to all registered participants and their registered accompanying persons.

Poster SessionAll posters will be on display during all days of the Congress.Monday 3 September 2007 to Wednesday 5 September 2007: 09:00 - 16:00Thursday 6 September 2007: 09:00 - 14:00Presenters should be at their poster board between 12:00 and 14:00 every day.Posters may be put up on Sunday 2 September 2007 from 09:00 to 16:00.Posters must be removed on Thursday 6 September 2007 before 16:00.The poster area is open to all registered participants.

Assembly of PharmacistsMonday 3 September 2007: 12:00 - 14:00The Assembly represents a major opportunity for FIP individual members to be involved with policy development within FIP. The FIP President, Kamal Midha, will report on the work of FIP. In particular there will be an opportunity to discuss a number of draft statements being prepared within FIP.

ExhibitionMonday 3 September 2007 to Wednesday 5 September 2007: 09:00 - 16:00Thursday 6 September 2007: 09:00 - 14:00The Exhibition is the responsibility of and organised by the Chinese Pharmaceutical Association and is open to all registered participants and their registered accompanying persons.

Monday 3 September 2007Welcome PartyThe Welcome Party will take place at the Jiuhua Spa & Resort, and is a chance for you to network with new contacts and catch up with old friends. In a friendly and informal atmosphere with drinks and snacks served generously, please come along and relax after the excitement of the first full day at the Congress. The Welcome Party is open to all registered participants and their registered accompanying persons.

Wednesday 5 September 2007Women for Pharmacy LunchSection DinnersTickets for this lunch and these dinners can only be purchased through East West Executive Travellers.

Thursday 6 September 2007Goodbye Dinner Party at the Great WallImagine having dinner at the Great Wall, one of the greatest wonders of the world and a UNESCO world heritage site; winding through deserts, grasslands, mountains and plateaus, the wall stretches up to 6,700 km and has a history of more than 2000 years. Enjoy the panoramic views of the surrounding while savouring a gourmet dinner!The Goodbye Dinner Party requires additional registration via the website registration form together with your online registration for the Congress.The number of seats is limited, therefore, if you would like to attend the Goodbye Dinner Party we advise you to order tickets in advance.Dress: informal.

GENERAL EVENTS SOCIAL EVENTS


SESSIONS PROGRAMME


PER DAY, PER SESSION ROOM(Sessions marked with * are accredited) Glossary – The following definitions are offered to provide clarity to those who review the Congress programme.

Conventional medicine (WHO) – The broad category of medical practice that is sometimes called Western medicine, biomedicine, allopathic medicine, scientific medicine, or modern medicine.

Complementary & alternative medicine (WHO) – A broad set of healthcare practices that are not part of a country’s own tradition and not integrated into the dominant healthcare system. Other terms sometimes used to describe these healthcare practices include natural medicine, non-conventional medicine and holistic medicine.

Anecdote (Webster’s New Collegiate Dictionary) – Literally, this word means “unpublished items.” It is often used to refer to short narratives or biographical incidents. In medicine, it is used to describe clinical experiences not based on randomised clinical trials, but many observations not scientifically evaluated.

Randomised clinical trials (Dawson-Saunders B, RG Trapp. Basic and Clinical Biostatistics) – A comparison of two treatment modalities to each other or one treatment modality to a placebo where subjects are randomly assigned to one group or the other. Said to be the gold standard because it provides the strongest evidence of causation and best assurance that the result was due to the intervention.

R = (PRE-)SATELLITE SYMPOSIAPlease note: All satellite symposia require separate registration via the website congress registration form together with your registration for the full congress.Deadline for registration for all pre-satellite symposia is 1 August 2007.Chinese delegates who wish to attend a pre-satellite can ONLY register for this on site at the registration desk, Friday 31 August 2007 from 08:00 to 09:30.

P = PROFESSIONAL SYMPOSIAS = SCIENTIFIC SYMPOSIAG = GENERAL SYMPOSIA

The following Symposia are co-sponsored by the World Health Organization P1 - PERSONAL, CULTURAL AND SOCIAL BELIEF

SYSTEMS AND THE USE OF MEDICINES Monday 3 September 2007P2 - REGULATORY, MANUFACTURING, SUPPLY

CHAIN AND qUALITY STANDARDS ISSUES Tuesday 4 September 2007P3 - TECHNICAL, SCIENTIFIC AND EVIDENCE

BASED INFORMATION RESOURCES ABOUT MEDICINES

Wednesday 5 September 2007P� - FUTURE ISSUES WITH CONVENTIONAL,

AND COMPLEMENTARY AND ALTERNATIVE MEDICINES

Wednesday 5 September 2007


FRIDAY 31 AUGUST & SATURDAY 1 SEPTEMBER 2007

ROOM 73

09:00 – 17:00*R2: PRE-SATELLITE WORKSHOP:STRATEGIES IN MEDICATION SAFETY – PHARMACOVIGILANCE AND PREVENTING MEDICATION ERRORS204 – 999 – 07 – 061 – L01FIP Pharmacy Information SectionFIP Special Interest Group on Pharmacoepidemiology/PharmacoeconomicsThe Uppsala Monitoring Centre/WHO Collaborating Centre for International Drug MonitoringSeparate registrationSeparate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2007.Learning objectivesAt the conclusion of this session, participants will be able to:- understand the basic principles of designing adverse drug reaction and medication

error reporting systems locally, nationally and internationally;- establish pharmacovigilance and patient safety programmes in their respective

institutions and/or countries;- understand key concepts and strategies to prevent medication errors – especially

the difference between product safety (pharmacovigilance) and process safety (preventing medication errors in healthcare);

- understand medication errors as a part of patient safety from a systems approach;- understand the importance of multidisciplinary cooperation in reporting ADRs

(Adverse Drug Reactions) and preventing medication errors at all levels;- discuss relevant policy initiatives and their current status in different continents;- understand how pharmacists can be advocates for reporting ADRs and preventing

medication errors in different settings;- communicate effectively with policy makers and the general public on medicine

safety.Chairs: Graeme Vernon, Austin Hospital, Australia and Keith Johnson, Management Sciences for Health, USAFaculty:Marja Airaksinen, University of Helsinki, FinlandAlexander Dodoo, University of Accra Medical School, GhanaRalph Edwards, WHO Uppsala Monitoring Centre, SwedenAndy Gray, University of KwaZulu-Natal, South AfricaKeith Johnson, Management Sciences for Health, USABert Leufkens, University of Utrecht, The NetherlandsAlan Lyles, University of Baltimore, USASten Olsson, WHO Uppsala Monitoring Centre, SwedenGraeme Vernon, Austin Hospital, Australia

Friday 31 August 2007Plenary session: Welcome and overview of the workshopPlenary session: Overview and importance of pharmacovigilance (Andy Gray)Plenary session: Reporting systems, potential for collaboration, and contribution to patient safety (Graeme Vernon)Small group discussion: Case studies (Faculty)Plenary session: Establishing a patient safety reporting programme: National and institutional examples, development of an international reporting system (Sten Olsson/Ralph Edwards)Small group discussion Plenary session: Getting the most out of data and data analysis (Bert Leufkens)Small group discussion: Case work in small groups (Faculty)

Saturday 1 September 2007Plenary session: Questions and discussion of all topics covered on Day 1 (Faculty)Plenary session: Effective communication practices in patient safety (Alexander Dodoo)Small group discussion: Case studies in communicating risk (Alexander Dodoo)Plenary Session: Putting the results of pharmacovigilance activities into the public policy and patient care arenas (Andy Gray)Plenary session: Process approach - Preventing medication errors in healthcare (Marja Airaksinen/Allan Lyles) Small group discussion: Case work in small groups (Faculty)Plenary session: Discussion of the issues raisedPlenary session: Taking action and taking the message home to share with others - Awarding of certificates (Faculty)

ROOMS 101, 102, 90, 71

09:00 – 13:00and 14:00 – 18:00R 1:PHARMACEUTICAL MANUFACTURING SCIENCE & PRACTICE FIP/CPA JOINT WORKSHOPSFIP Industrial Pharmacy SectionChinese Pharmaceutical AssociationSeparate registrationSeparate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2007.1. Good Manufacturing Practices for the 21st century

Chair: Michael Anisfeld, Globepharm, USA Co-Chairs: Wenfang Xu, Shandong University and Zhe Che, Shenzen FDA, China2. Quality by Design and Quality Risk Management

Chair: Tom Sam, N.V. Organon, The Netherlands Co-Chairs: Xinyong Liu, Shandong University and Bin Xue, State FDA, China3. Tabletting, process analytical and controlled-release technologies Chair: Adel Sakr, University of Cincinnati Medical Center, USA Co-Chairs: Guoan Luo, Tsinghua University and Jinghua Zhang, Guangdong FDA,

China4. Parenteral technology, validation and quality assurance Chair: Matthew Cherian, Patheon, Italy Co-Chairs: Wan-Liang Lu, Peking University and Giancarlo Petruzzi, Sanofi Pasteur,

China


ROOM 106

09:00 – 14:00R 3:INTRODUCTION TO CHINESE PHARMACY PRACTICEFIP Community Pharmacy SectionWould you like to know more about pharmacy practice in China, about drug distribution and traditional Chinese medicine? If so, we would like to invite you to a programme consisting of, in part, a seminar with presentations by Chinese experts and, in part, visits to different types of pharmacies in Beijing.The programme is organised in collaboration with the Chinese Pharmaceutical Association.Separate registrationFor logistic reasons, separate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2007. As the programme has limited access, early registration is recommended. Registration will be handled on a first-come first-served basis.Managing Chair: Eugene Lutz, FIP Community Pharmacy Section, USACo-Chair: Wang Yuqin, Capital University of Medical Sciences, ChinaIntroduction to the healthcare system in ChinaCai Renhua, Shanghai Jiaotong University, ChinaLei Haichao, Ministry of Health, ChinaWei Jigang, Development Research Center State Council, ChinaDrug distribution in ChinaZhu Changhao, China Association of Pharmaceutical Commerce (CAPC), ChinaWang Jinxia, CAPC, ChinaTraditional Chinese medicineChen Keji, China Academy of Sciences, ChinaLiu Baoyan, China Academy of Chinese Medical Sciences, ChinaPharmacy visitsQuan Xin Pharmacy of Beijing Pharmaceutical Co. Ltd., China

SATURDAY 1 & SUNDAY 2 SEPTEMBER 2007ROOM 102

Saturday 1 September 200713:00 – 17:00* R �:FORUM FOR INNOVATORS IN PHARMACY PRACTICEPharmacist advice at the counter – Implementation of Best Practice Standards204 – 999 – 07 – 062 – L04FIP Community Pharmacy SectionThe Forum for Innovators in Pharmacy Practice is a new concept, developed with the purpose of creating a forum for sharing experience and exchanging information. Participants are invited to bring topic-related material to the Forum for presentation and discussion. It is the intention to make this Forum an annually recurring event to facilitate networking on a continuous basis. Community pharmacy organisations all over the world work at developing the health professional role of the pharmacy. It is of key importance to the profession that patients, customers, authorities, politicians, health professionals and the media, in their personal contact with the pharmacy, experience a high professional quality, which, for obvious reasons, is important to safety and quality of drug use, and to customer satisfaction. Several pharmacy organisations have worked on developing standards to ensure the quality of this important activity, and some have set out to ensure nationwide dissemination and implementation of their standards. Most have found this to be hard work, and we can, undoubtedly, learn much from each other. The Forum for Innovators aims to provide such a learning environment. Target audienceProject coordinators, employees in member organisations and educators dealing with pharmacy practice development and implementation of pharmacy-based services. Separate registrationSeparate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2007. Learning objectivesAt the conclusion of this session, participants will be able to:- understand the importance of developing and implementing standards for best

practice;- identify and discuss factors influencing implementation of standards;- explain methods for measuring implementation;- develop an implementation plan.Managing Chair: Hanne Herborg, Pharmakon, DenmarkCo-Chair: Charlie Benrimoj, University of Sydney, AustraliaPharmacist advice at the counter - Implementation of Best Practice Standards - A global perspectiveKeynote lectureCharlie Benrimoj, University of Sydney, Australia 1. Content of standardsSetting standards for best practice - An example from Australia Alison Roberts, University of Sydney, AustraliaSetting standards for best practice - An example from Denmark Lotte Fonnesbæk, Pharmakon, DenmarkExperience exchange in small groups2. Measuring quality and disseminationDissemination, quality control and documentation - An example from Australia Alison Roberts, University of Sydney, AustraliaDissemination, quality control and documentation - An example from Denmark Lotte Fonnesbæk, Pharmakon, DenmarkExperience exchange in small groups

Sunday 2 September 200709:00 – 12:303. ImplementationHow to implement Best Practice Standards: Prerequisites, facilitators, tools, incentives and sanctions - An example from Australia Alison Roberts, University of Sydney, AustraliaHow to implement Best Practice Standards: Prerequisites, facilitators, tools, incentives and sanctions - An example from Denmark Lotte Fonnesbæk, Pharmakon, DenmarkWorking session: How to make an implementation plan The audience is divided into working groups.Report from working session and discussion

SATURDAY 1 SEPTEMBER 2007


ROOM 103

09:00 – 12:00* P 1:PERSONAL, CULTURAL AND SOCIAL BELIEF SYSTEMS AND THE USE OF MEDICINES204 – 999 – 07 – 063 – L04FIP Board of Pharmaceutical PracticeGlobalisation has made the world smaller and each culture is less isolated. Various aspects of each culture and healthcare practices including the medicines used have evolved separately over time. Not only are the medicines themselves different, but the approaches to developing, evaluating, and using them are also different. Conventional medicine has evolved into a scientific approach compared to reliance on sometimes long-term experience with complementary & alternative medicines. Do these differences matter? Is one approach better than the other? Can, or should they be reconciled? The purpose of this symposium is to explore the cultural aspects of what patients expect from their medicines, how they use conventional, and complementary & alternative medicines.Learning objectivesAt the conclusion of this session, participants will be able to:- understand health belief models which underpin the theory of medicine taking behaviour;- describe what medicines patients actually take;- describe how patients decide what medicines to take, and the information they use;- discuss the possibility of considering conventional, and complementary & alternative medicines as members of

the same family.Managing Chair: Martin Schulz, FIP BPP Programme Committee, GermanyCo-Chair: Li Dakui, Peking Union Medical College, ChinaIntroduction to the Professional SymposiaMartin Schulz, FIP BPP Programme Committee, GermanyHealth beliefs – How decisions are made to use medicinesSjaak van der Geest, University of Amsterdam, The Netherlands Patterns of medicines use – What are patients taking? Ebba Holme Hansen, Danish University of Pharmaceutical Sciences, DenmarkHow do patients decide what medicines to take, and what information do they need?Theo Raynor, Leeds University, United KingdomCurrent issues with the use of conventional, and complementary & alternative medicines: A WHO perspective Xiaorui Zhang, World Health Organization, Switzerland

14:00 – 17:00BPP/BPS JOINT SYMPOSIUM (PART I)FIP Board of Pharmaceutical PracticeFIP Board of Pharmaceutical SciencesThis Symposium will discuss the extent of the global counterfeit medicine problem, and how to stop Active Pharmaceutical Ingredients from being used to produce counterfeit medicines. It will also discuss how to keep counterfeit medicines out of the drug supply chain and how to detect them once in the drug supply chain.Learning objectivesAt the conclusion of this session, participants will be able to describe:- definitions of counterfeit medicines;- the adverse consequences on public health of counterfeit medicines;- the role of organised crime in the production and distribution of counterfeit medicines;- the role of government regulatory agencies, pharmacopeias, and industry in insuring the quality and safety

of pharmaceutical ingredients (drug substances and excipients) and ensuring compliance with Good Manufacturing Practices (GMP);

- the role of customs and law enforcement agencies in stopping APIs from leaving or entering countries for use in the production of counterfeit medicine products;

- the need for health, customs, law enforcement officials and industry to work together and to globally share information to catch counterfeiters and to stop APIs from being used in the production of counterfeit drugs;

- World Health Organization and APEC Life Science Innovation Forum counterfeit medicine activities;- the development of a shared data bank including best practices, and information on counterfeiters;- how to ensure safe medicines in the medicine supply chain; the role of government regulatory agencies,

pharmacopeias, hospitals, pharmacists, doctors, nurses, and the pharmaceutical industry;- drug safety verification and certification programmes;- harmonised standards for pharmaceutical ingredients (drug substances and excipients) validation of

procedures, impurities, etc.);- the role of track and trace technologies, such as radio frequency identification (RFID), and authentication

technologies;- the sharing of information on shipments of pharmaceutical ingredients (drug substances and excipients);- tracking flow of funds, movement of finished products, and Internet purchases;- low technology detection methods.Chairs: Jeffrey Gren, Office of Health Consumer Goods, USA and Nancy Blum, United States Pharmacopeia, USAIMPACT update Howard Zucker/Valerio Reggi, World Health Organization, Switzerland (invited)Trade and commerce perspective Jeffrey Gren, Office of Health and Consumer Goods, USARegional approaches to monitoring drug quality Nancy Blum, United States Pharmacopeia, USATrack and trace of shipments Harvey Bale, International Federation of Pharmaceutical Manufacturers & Associations, Switzerland (invited)Analytical and surveillance Shaohong Jin, National Institute for Control of Pharmaceutical and Biological Products, China (invited)

ROOM 10�

09:00 – 12:00* G 1:LIFE LONG LEARNING AND CONTINUING PROFESSIONAL DEVELOPMENT: WE HAVE ALL HEARD THE THEORY, WHAT IS THE EVIDENCE?204 – 999 – 07 – 067 – L04FIP Academic Pharmacy SectionLearning objectivesAt the conclusion of this session, participants will be able to:- understand the perceived barriers to pharmacists

undertaking CPD;- discuss mechanisms by which CPD can be delivered

to overcome barriers to participation;- describe some examples of what people have actually

achieved using the CPD process as part of their LLL plan;

- explain how the outcomes of CPD have benefited individuals, organisations and pharmacy practice.

Chair: Claire Anderson, University of Nottingham, United KingdomPerceived barriers to pharmacists undertaking CPDJennifer Marriott, Monash University, Australia Challenges in implementing a pilot CPD programme in the USA: Lessons learnt Alan Hanson, University of Wisconsin-Madison, USAWe have all heard the theory, what is the evidence? Jennifer Archer, University of Manchester, United Kingdom

14:00 – 17:00* G 2:EXPERIENTIAL LEARNING – BRIDGING CLASSROOM EDUCATION AND PHARMACY PRACTICE204 – 999 – 07 – 068 – L04FIP Academic Pharmacy SectionInternational Pharmaceutical Students’ FederationThis three-hour joint session will explore the concept and value of practice-based experiential learning in pharmacy curricula. Issues such as the challenges faced in integrating experiential learning in pharmacy curricula, preceptor education and quality assurance of experiential learning will be discussed. The session is targeted at individuals and key stakeholders involved or interested in the design and implementation of pharmacy curricula and pharmaceutical services.Learning objectivesAt the conclusion of this session, participants will be able to:- define experiential learning;- recognise and evaluate the impact of and need for

experiential learning in pharmacy curricula;- identify and discuss the challenges faced in the

implementation and integration of experiential learning in pharmacy curricula;

- describe the education of preceptors supervising students’ experiential learning;

- discuss assessment and accreditation issues in the quality assurance of experiential learning in pharmacy education.

Chairs: Claire Anderson, University of Nottingham, United Kingdom and Audrey Clarissa, International Pharmaceutical Students’ Federation, IndonesiaEvidence-based impact of experiential learningIan Bates, University of London, United KingdomIntegrating experiential learning into curricula – Global students’ views of the challengesZhining Goh, IPSF, SingaporePreceptor education to improve student learningJennifer Marriot, FIP Academic Pharmacy Section, AustraliaQuality assurance of experiential learning – Assessment and accreditationMike Rouse, Accreditation Council for Pharmacy Education, USA

MONDAY 3 SEPTEMBER 2007


ROOM 101

09:00 – 12:00* G 9:FIP/IPSF STUDENTS’ DAY:SOCIAL DIMENSIONS OF DEVELOPING THE PHARMACY PROFESSION 204 – 999 – 07 – 074 – L04FIP International Pharmaceutical Students’ FederationThis three-hour session will explore the role of sociology in the pharmacy profession. The impact of culture and gender on pharmacy practice and workforce development will be discussed. The social aspects in the provision of patient-focused care as well as the ‘Brain Drain’ issue in pharmacy will also be addressed. Target audienceThe session is targeted at local and international student pharmacists to create an awareness of the importance of the social dimensions of pharmacy amongst them. It also targets pharmacy professionals and other individuals involved or interested in the social aspects of the pharmacy profession. Learning objectivesAt the conclusion of this session, participants will be able to:- recognise the role of sociology in pharmacy workforce development;- appreciate the views of students and young pharmacists on the social dimensions of the pharmacy

profession;- describe the concept and impact of culture on the pharmacy profession;- identify push and pull factors and areas for intervention and mobility in the field of pharmacy;- identify and appreciate the implications of mobility trends on pharmacy practice and workforce

development;- discuss the social aspects of pharmacy pertaining to the enabling and provision of patient-focused

care;- identify and describe the impact of gender trends and issues on the development of the pharmacy

profession.Chairs: Zhining Goh, International Pharmaceutical Students’ Federation, Singapore and Audrey Clarissa, IPSF, Indonesia Introduction – Connecting sociology with pharmacy Zhining Goh, IPSF, SingaporeAddress from FIP Kamal Midha, FIP President, CanadaThe impact of culture on pharmacy practice and professionalism Billy Futter, Rhodes University, South AfricaDrivers of migration and their impact on pharmacy practice Tana Wuliji, IPSF & FIP, New Zealand Patient-focused care Catherine Duggan, The Royal London Hospital, United KingdomGender and pharmacy Ian Bates, University of London, United Kingdom

14:00 – 17:00* G 10:FINANCING THE HEALTHCARE204 – 999 – 07 – 075 – L04FIP Young Pharmacists GroupThe Educational Forum introduces key models of financing healthcare systems (The World Health Report 2000, WHO) and looks how they affect the pharmacy practice (community and hospital). It is designed to inform the participants about the advantages and disadvantages of the existing funding models and outlines common trends in recent healthcare reforms in different countries.It goes along classification and comparison of the healthcare systems to deepen into concepts of managed healthcare and equality of healthcare provision. It outlines novel roles for pharmacists in management of healthcare. Finally, it provides examples, how the recent healthcare reforms in healthcare financing have provided room for development and additional diversification in the pharmacy services.Learning objectivesAt the conclusion of this session, participants will be able to:- identify different models of financing the healthcare systems;- outline major trends in development of the healthcare systems;- describe potential roles for the pharmacists in management of healthcare;- understand the role of the funding mechanisms on the development of pharmacy practice.Chair: Boyan Todorov, FIP Young Pharmacists Group, BulgariaClassifying and comparing health systemsGisselle Gallego, Centre for Health Economics Research and Evaluation, AustraliaHealthcare management organisations and the pharmacy profession in the USAJanet Silvester, Pharmacy Services Martha Jefferson Hospital, USADecentralisation and equity of healthcare provision in Finland Reijo Kärkkäinen, Association of Finnish Pharmacies, FinlandImpacts of the healthcare system reforms on the professionSpeaker TBA, GermanyNational Health Service: Funding mechanism and impact on the professionLindsay McClure, Pharmaceutical Services Negotiations Committee, United Kingdom

ROOM 102

09:00 – 12:00S 1:DISSOLUTION TESTING: A PIVOTAL TOOL FOR DEVELOPMENT AND qUALITY OF DRUGSFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Dissolution/In Vitro Release Performance TestingChairs: Horst-Dieter Friedel, Bayer HealthCare, Germany and Naoki Kamo, Japan IntroductionDissolution of solid oral dosage forms: Method developmentHorst-Dieter Friedel, Bayer HealthCare, GermanyIn vitro release testing of novel dosage formsCynthia Brown, Lilly, USAQuality by design Lucinda Buhse, Food and Drug Administration, USADissolution test for parenteralsMary Stickelmeyer, Lilly, USA

14:00 – 17:00S 2:PHARMACOEPIDEMIOLOGY: (a) HEPATITIS MODEL & (b) ANTIBIOTIC RESISTANCEFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Pharmacoeconomics/PharmacoepidemiologyChairs: Wei Lai, Peking University, China and Tatsuro Irimura, University of Tokyo, JapanExperience in blocking hepatitis in new born childrenWei Lai, Peking University, ChinaSpecific model for studying hepatitis drugs Speaker TBA A new approach in glycomics and disease markersTatsuro Irimura, University of Tokyo, JapanEpidemiological resistance Richard Laing, World Health Organization, Switzerland (invited)


programme updates:


1� WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

ROOM 106

09:00 – 12:00* G 17:PHARMACEUTICALS AND THE ENVIRONMENT204 – 999 – 07 – 079 – L04FIP Community Pharmacy SectionFIP Industrial Pharmacy SectionLimiting the spreading of substances that do not occur naturally in the environment is central to the protection of the environment. Unnatural substances are inevitable in our society. Environmental activities must, therefore, concentrate on investigating and revealing their properties and on ensuring that they have minimal impact on the environment and that their use and disposal take place in a manner that, as far as possible, prevents them from spreading. Pharmaceuticals contain chemical substances and are, therefore, an important area to take into account, in the striving to achieve a non-toxic environment. Having control of their environmental aspect is essential when drugs are developed and it contributes to utilisation in the best possible way. Environmental issues should never become a reason to refrain from medical treatment based on drugs. Target audiencePharmacists working in community pharmacy, in hospital pharmacy or in the military; pharmacists in the pharmaceutical industry; young pharmacists, students and educators.Learning objectivesAt the conclusion of this session, participants will be able to:- describe the challenge in keeping the environment free of drug residuals;- list the risks to humans, fauna and flora;- understand the environmental classification of medicines;- discuss risk factors of environmental pollution caused by medicine.Managing Chair: Astrid Kågedal, Apoteket AB, SwedenCo-Chair: Erich Sturzenegger, Novartis, SwitzerlandPharmaceuticals and the environment Klaus Kümmerer, Freiburg University, GermanyDrug residues in the environment: Levels and risksÅke Wennmalm, Stockholm County Council, Sweden Environmental classification of drugsBo Gunnarsson, Apoteket AB, SwedenLessons from early warnings and the precautionary principle David Gee, European Environment Office, Denmark The role of the community pharmacy Dominique Jordan, FIP Community Pharmacy Section, Switzerland

14:00 – 17:00* G 18:HOW TO GUARANTEE THE BEST THERAPEUTIC OUTCOME OF A PHARMACEUTICAL PRODUCT – THE INFLUENCE OF A LIFE CYCLE204 – 999 – 07 – 080 – L04FIP Community Pharmacy SectionFIP Industrial Pharmacy SectionThe stakeholders in the drug distribution channel – from the pharmaceutical industry to the pharmacy – have a joint responsibility, throughout the life cycle of a drug, to ensure effectiveness and the best therapeutic outcome of pharmaceutical products. This demands a high quality in the product and in the information available to healthcare professionals and patients in order to ensure the best use of the drug. The ultimate goal is safe and correct use of pharmaceuticals for the sake of patient safety and obtaining the best therapeutic outcome. Target audiencePharmacists working in community pharmacy, hospital pharmacy or in the pharmaceutical industry; young pharmacists, students and educators.Learning objectivesAt the conclusion of this session, participants will be able to:- identify the risks of improper information and dispensing to product safety;- understand the financial and rational consequences of poor adherence and wrong usage of medicines to

the medical industry and to the patient;- discuss the responsibility of the pharmacist to support adherence.Managing Chair: Eeva Teräsalmi, FIP Community Pharmacy Section, FinlandCo-Chair: Tom Sam, FIP Industrial Pharmacy Section, The NetherlandsAdherence – A world-wide problem Speaker TBA, World Health Organization, SwitzerlandHow can the pharmaceutical industry support dispensing and proper counselling to achieve better adherence? Ulf Janzon, Merck Sharp & Dohme, SwedenThe responsibility of the community pharmacists to support adherence – How is it done? Rai Vaidya, Hindu Pharmacy Goa, IndiaMedicines can cure only when taken properly - A campaign run by The Association of the Finnish Medical IndustryAuni Saarinen, Pharmaceutical Information Centre Ltd., Finland

MONDAY 3 SEPTEMBER 2007

67th INTERNATIONAL CONGRESS OF FIP 1�

ROOM 107

09:00 – 12:00* G 2�:ANTIMICROBIAL DRUG RESISTANCE – THE ROLE OF THE PHARMACY PROFESSION IN TACKLING THIS EMERGING GLOBAL HEALTH PROBLEM204 – 999 – 07 – 082 – L01FIP Pharmacy Information SectionAntimicrobial Drug Resistance (AMR) is an emerging global health problem that, if not addressed immediately and properly, may advance into one of the most significant public health challenges worldwide. Within the last few years many governmental and non-governmental bodies, such as the UK House of Lords, the EU Chief Medical Officers of Health, the WHO, the US Centers for Disease Control and Prevention (CDC) and a US Senatorial Bipartisan Committee have all indicated that AMR is a major threat to public health.The steady increase in AMR continues despite the introduction of new antibiotics. AMR is associated with increased patient morbidity and mortality as well as with increased costs. Addressing the problem of AMR requires both infection control and regulation of antibiotic use. Reports from professional organisations and a consensus of experts have outlined strategies for the control of resistance in hospitals and in the community. However, the importance of a multidisciplinary approach in tackling the problem of AMR should be emphasised. This symposium will examine the many facets associated with AMR with an emphasis on the role of health-related professional organisations.Learning objectivesAt the conclusion of this session, participants will be able to:- define issues and potential solutions to the problem of AMR, and to discuss the science, prevention and

control of AMR;- define the role of pharmacy-related professional organisations and institutions in creating an effective

programme in relation to AMR, that can be readily incorporated into the quality-improvement goals of any healthcare organisation;

- identify the information resources that will assist healthcare professionals, especially those in developing countries, on developing and disseminating information on the appropriate use of antimicrobials in order to reduce the incidence of AMR;

- help health-related professional organisations, especially those related to pharmacy, in developing Position Statements on AMR which will be used in setting strategies to reduce the problem of AMR.

Chair: Daniel Seyoum, United States Pharmacopeia, USACo-Chair: TBAAntimicrobial Drug Resistance – The next pandemicDaniel Seyoum, USP, USAThe role of programmes related to drug quality and information in addressing the problems and solutions to AMRSouly Phanouvong, USP, USAThe role of pharmaceutical societies in fighting the global problem of AMRSpeaker TBAThe role of international, governmental, and non-governmental agencies in fighting the problem of AMRTwo speakers TBAPanel discussion

14:00 – 17:00* G 26:RISK COMMUNICATION IN PATIENT SAFETY: TO WHAT EXTENT CAN PICTOGRAMS HELP IN LABELING?204 – 999 – 07 – 083 – L04FIP Pharmacy Information SectionFIP Military & Emergency Pharmacy SectionThe safe use of medicines depends on many factors, such as safe storage, safe prescribing, safe dispensing and counseling. Various techniques have been developed to support these processes in which effective risk communication has been identified as crucial part of improving patient safety. This session will focus on the role of the pharmacist in improving risk communication, especially by using pictograms. Valuable insight from projects where effective risk communication has made a significant contribution to safe and effective use of medicines will be provided.Learning objectivesAt the conclusion of this session, participants will be able to:- describe various techniques to communicate risk of improper use of medicines;- explain the role of the pharmacist in establishing standards to communicate risk in patient safety;- list the various methods which have shown to be effective in communicating risk;- discuss the usefulness of the various tools for changing the practice;- describe the impact of literacy on risk communication;- describe the process to develop culture specific pictograms to label medications;- describe the use of pictograms with children.Chairs: Jane Dawson, Headquarters New Zealand Defence Force, New Zealand and Marja Airaksinen, University of Helsinki, Finland Risk communication: An introduction Peter Knapp, University of Leeds, United KingdomThe FIP BPP project: Results of field-studies on pictogram useJane Dawson, Headquarters New Zealand Defence Force, New ZealandThe use of pictograms in diabetes careRégis Vaillancourt, Children’s Hospital of Eastern Ontario, CanadaRisk communication in drugs and driving Han de Gier, University of Groningen, The NetherlandsHow pictograms work with children Katri Hämeen-Anttila, University of Kuopio, Finland

ROOM 90

09:00 – 12:00G 33:WORKSHOP: NUCLEAR/RADIOLOGIC PHARMACYFIP Special Interest Group on Nuclear/Radiologic PharmacyThe workshop is designed to provide current information related to Nuclear Pharmacy practice and its implementation. Subjects addressed will be Aseptic Control Requirements and procedures unique to nuclear pharmacy practice. Issues such as equipment, individual technique validation, environmental control parameters specific to the nuclear pharmacy environment and aseptic process will be considered. Radiopharmaceutical Quality Control Manual will include methodology and practical aspects of QC specific to radiopharmaceuticals. It will also provide the basis of a QC Manual applicable to current radiopharmaceutical QC procedures. Operational Guidelines on Hospital Radiopharmacy will address hospital unique aspects of nuclear pharmacy practice. Finally, New Trends in Nuclear Pharmacy encompasses new agents and new applications of radiopharmaceuticals in medicine.Target audience Pharmacists interested in exploring and/or initiating Nuclear Pharmacy servicesChairs: Eduardo Savio, Facultad de Química, Uruguay and Clyde Cole, Amersham Health, USAWelcome and introduction Clyde Cole, USA and Eduardo Savio, UruguayCurrent considerations of Aseptic Control Requirements for Nuclear PharmacyClyde Cole, USAIAEA Operational Guide on Hospital RadiopharmacyK. Solanky, AustriaA Radiopharmaceutical Quality Control ManualKara Weatherman, USA New trends in Nuclear PharmacyEduardo Savio, Uruguay

14:00 – 17:00* G 3�:CLINICAL BIOLOGY IN SOUTH EAST ASIA204 – 999 – 07 – 089 – L01FIP Clinical Biology SectionInternational Federation of Clinical Chemistry (IFCC)This session is aimed at tackling clinical biology in South East Asia.Learning objectivesThis session should allow participants to better know each other, by presenting the health system in China and the evolution of clinical biology in the world.At the conclusion of this session, participants will:- know the training for clinical biology in China to be able to

compare it to the rest of the world;- know the evolution of C hepatitis in South East Asia;- see how clinical biology can make a contribution to Asiatic

alternative medicines.Chair: François Trivin, France and TBA, ChinaOrganisation and training of healthcare and clinical biology in ChinaSpeaker TBA, ChinaC Hepatitis in South East AsiaMonelle Muntlak, Roche Diagnostiques, FranceClinical biology contribution to complementary and alternative medicines Patricia Cannone-Fourquet, Laboratoire d’Analyses Médicales de Nîmes, FranceEvolution of clinical biology at international levelFrançoise Memmi, Conseil Central des Pharmaciens Biologistes, France

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES16

ROOM 72

09:00 – 18:00FIP SPECIAL INTEREST GROUP MEETINGS09:00-10:00 Pharmacoepidemiology/Pharmacoeconomics10:00 – 11:00 Natural Substances11:00 – 12:00 Pharmaceutical Biotechnology 12:00 – 13:00 Individualised Medicine13:00 – 14:00 Nuclear/Radiologic Pharmacy14:00 – 15:00 Dissolution/In Vitro Release Performance Testing 15:00 – 16:00 Biopharmaceutics Classification System16:00 – 18:00 All SIG Chairs Meeting

ROOM 71

09:00 – 17:00PHARMACEUTICAL DISTINCTIVE FEATURES OF DIFFERENT COUNTRIES DURING THEIR HISTORYFIP Working Group on the History of PharmacyChair: Jacques Gravé, Sauvegarde du Patrimoine Pharmaceutique, France

ROOM 103

09:00 – 12:00* P 2:REGULATORY, MANUFACTURING, SUPPLY-CHAIN AND qUALITY STANDARDS ISSUES204 – 999 – 07 – 064 – L04FIP Board of Pharmaceutical PracticeThere are fundamental differences in how complementary & alternative medicines are discovered, manufactured, prepared, dispensed, used, and the outcomes measured compared to conventional medicines. The purpose of this symposium is to compare and contrast these differences at each stage of the life of a medicine – from discovery to clinical outcome.Learning objectivesAt the conclusion of this session, participants will be able to:- compare and contrast how conventional, and complementary & alternative

medicines are discovered;- compare and contrast how conventional, and complementary & alternative

medicines are manufactured, prepared and quality assured;- compare and contrast how conventional, and complementary & alternative

medicines are obtained and used by patients and the role of the pharmacist;- compare and contrast the safety and efficacy of conventional, and complementary

& alternative medicines.Managing Chair: Lindsay McClure, FIP BPP Programme Committee, United KingdomCo-Chair: Vincent Lee, Hong Kong Pharmacy School, ChinaDiscovery, development and preparationHow do we find, make, and assure quality of complementary & alternative medicines?De-An Guo, Shanghai Research Center for Modernisation of Traditional Chinese Medicine in the Chinese Academy of Sciences, ChinaHow do we find, make, and assure quality of conventional medicines?Mona Tawab, Central Laboratory of German Pharmacists, GermanyUse and outcomesHow do patients obtain, use, and benefit from complementary & alternative medicines?Nigel Gericke, South AfricaHow do patients obtain, use, and benefit from conventional medicines?Peter Noyce, Commission on Human Medicines, United Kingdom

14:00 – 17:00BPP/BPS JOINT SYMPOSIUM (PART II)FIP Board of Pharmaceutical PracticeFIP Board of Pharmaceutical SciencesThis part of the Symposium will examine the extent of counterfeiting in China and India and the development of screening methods. The shortcomings of current national legislation will be reviewed and consumer advice and public awareness campaigns will be discussed.Learning objectivesAt the conclusion of this session, participants will be able to understand: - the strategies of combating counterfeit medicines in China and India;- procedures under development in regulatory authorities and the pharmaceutical

industry for the screening of counterfeits;- the current national legislation in countries that represent 80% of the world

population- methods to involve the public in national campaigns against counterfeits.Chair: Jane Nicholson, FIP Working Group on Counterfeit Medicines, United KingdomCombating counterfeit medicines in the Guangdong provinceZhang Jing Hua, Food and Drug Administration Guangdong, China Consumer advice and public awareness campaignsJane Nicholson, FIP Working Group on Counterfeit Medicines, United KingdomA model to estimate the extent of counterfeit medicinesPrafull Sheth, South East Asia Regional Forum, IndiaModern screening methods in actionTony Moffat, University of London, United KingdomCounterfeiting drugs is murder – Current national legislative responsesMichael Anisfeld, Globepharm Consulting, USA

MONDAY 3 SEPTEMBER 2007 TUESDAY � SEPTEMBER 2007

67th INTERNATIONAL CONGRESS OF FIP

HOUSINGThe following pages can be separated from this programme booklet. The Sessions programme continues on page 17.

OFFICIAL HOUSING AGENTFor ALL your hotel reservations:China Commercial International Travel Service (CCITS)45 Fuxingmennei StreetBeijing 100801ChinaTel: (+86) 10 51656540 / 66062448 Fax: (+86) 10 6609 5637E-mail: [email protected]

[email protected]

VENUE AND HEADQUARTERS HOTELJiuhua Spa & ResortChang Ping Xiao Tang Mountain102211 BeijingChinaTel.: (+86) 10 61782288Fax: (+86) 10 61782246Website: www.jiuhua.com.cn

IntroductionIn the east of Changping District of Beijing, lies Jiuhua Spa & Resort. As a royal palace in the old days, Jiuhua features a deep accumulation of culture, which is reflected in its architecture based on the Ming & Qing style. Jiuhua Spa & Resort is situated next to the Six Ring Road, and only twenty minutes’ drive from Beijing International Airport. It has 1200 guestrooms and suites, ten restaurants in all districts, a shopping mall, bowling and tennis center. All buildings are inter-connected by mono-rail which is free of charge. It stops at every building and the entire trail takes 15 minutes. AccommodationFrom a royal palace in the past to a world-renowned international hotel resort, Jiuhua Spa & Resort offers a choice selection of guest rooms varying from villas for up to 6 persons with private hot springs, to various categories of rooms.MeetingsWhere business combines with pleasure: The Convention and Exhibition Centre at Jiuhua Spa & Resort is equipped with complete business and meeting facilities that are supported by a high standard of service to cater from small-sized meetings to large conventions. Hot springRejuvenate your spirit at the hot spring: It is said that the waters of the hot spring create a mythical surrounding… Jiuhua’s Xiaotangshan Hot Spring, since the old days, is one of China’s four major hot springs, abundantly rich in minerals and elements which are beneficial to your health. Each building has a number of professional massage facilities which are also highly recommended.

JIUHUA CONVENTION & EXHIBITION CENTERHOTEL (16 District Area, *****)

Standard Twin RoomRoom rate per night: 100 Euro (= RMB 1000)Number of rooms available: 900Included: standard room package in ALL room categories:- 1 person’s buffet breakfast, buffet lunch,

morning and afternoon coffee/tea break, tax, shuttle bus airport pick up during the convention;

- Extra buffet breakfast: 6 Euro (= RMB 60) per person;

- Extra buffet lunch, coffee/tea break congress participants: 20 Euro (= RMB 200) per person/day;

- Free computer and internet access;- Water dispenser & refrigerator;- Central air-conditioning system; - Community antenna/satellite television; - Writing table;- Private safe; - Private bathroom.

Standard Single RoomRoom rate per night: 100 Euro (= RMB 1000)Number of rooms available: 200Included: standard room package

Business SuiteRoom rate per night: 160 Euro (= RMB 1600)Number of rooms available: 40Included: standard room package + high-class bathtub / detached bath / sauna

Minister SuiteRoom rate per night: 600 Euro (= RMB 6000)Number of rooms available: 4Included: standard room package + high-class bathtub / detached bath / sauna + private locker room

PAYMENT, CHANGE, CANCELLATION AND REFUND POLICYFull payment as deposit of the requested hotel is requested 10 days after receiving our preliminary confirmation. All reservations require a guarantee with a valid credit card, otherwise, your reservation will be released. The payment of your stay will be settled in the hotel, and will not be refunded in case of no show on the specific arrival date you have booked.

Notifications of cancellations and changes can be made online or in writing to official housing agency CHINA COMMERCIAL INTERNATIONAL TRAVEL SERVICE (CCITS). An administration fee of 40 Euro ( = RMB 400) per room will be charged for cancellations before 31 July 2007.50% of the deposit will be charged in case of cancellation of the reservation between 31 July 2007 and 15 August 2007. After 15 August 2007 deposit(s) is/are non-refundable, and no refund claims will be handled within 48 hours prior to the arrival date.

JIUHUA GRAND HOTEL (15 District Area,****, 3 minutes walking distance to 16 District Area )

Standard Twin RoomRoom rate per night: 88 Euro (= RMB 880)Number of rooms available: 340Included: standard room package

Standard Single Room Room rate per night: 88 Euro (= RMB 880)Number of rooms available: 20Included: standard room package

Single Suite Room rate per night: 120 Euro (= RMB 1200)Number of rooms available: 14Included: standard room package

Executive Suite Room rate per night: 140 Euro (=RMB 1400)Number of rooms available: 50Included: standard room package

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

TOURS

East West Executive Travellers Pte Ltd5, Temasek Boulevard#12-05, Suntec Tower 5Singapore 038985Tel.: (+65) 6238 8488Fax: (+65) 6238 8878E-mail: [email protected]: www.ewet.com

East West Executive Travellers have been appointed for pre- & post congress tours as well as tours during the congress week. They will also handle all reservations for the Section Dinners and Lunches.

PRE- & POST CONGRESS TOURS(minimum attendance required for all tours)

XIAN SPLENDOR (2 Days 1 Night)Beijing – Xian - BeijingAccommodation, transfers, 1 breakfast, 2 lunches, 1 dinnerPrice per person – € 470 single / € 430 doubleOne of the most ancient capitals of the world, Xian is endowed with historical sites, rich cultural relics, and beautiful scenery that makes it awe inspiring. This city served as the capital seat of twelve dynasties for more than 1100 years, and its Wei valley is the legendary birthplace of Chinese civilization. It was here that the mythical Yellow Emperor (third millennium BC) conquered the other warring tribes to give birth to the Chinese nation. Revel at the majestic spectacle of the Terra Cotta Warriors and its multiple museums & mosques.

GRAND SHANGHAI (3 Days 2 Nights)Beijing – Shanghai - BeijingAccommodation, transfers, 2 breakfasts, 2 lunches, 2 dinnersPrice per person – € 498 single / € 395 doubleShanghai is the hotspot of modern China; a cosmopolitan city buzzing with the concept of ‘lifestyle revolution’, showcased in the architectural temples of art, fine dining and

contemporary urban living on the Bund. Enlivened by the presence of outstanding museums, temples & local culture, you will find yourself amazed at the extent of historical, cultural and cosmopolitan activities that you can indulge in.

GOLDEN CHINA (5 Days 4 Nights)Beijing – Xian – Shanghai - BeijingAccommodation, transfers, 1 breakfast, 2 lunches, 1 dinnerPrice per person – € 785 single / € 640 doubleXian, the eternal city and Shanghai, the cosmopolitan city, provides for a brilliant and contrasting experience that showcases the history, traditions, culture and glamour of China

in a truly unique and dynamic combination that best brings out the antiquity and trendsetting persona of the country. From the archeological spectacle of the terra cotta warriors to the scenic beauty of the hot springs in Xian to the unending charm of Yuyuan Garden and Bazaar to the outstanding entertainment of the bund and around the city, you will be spoilt for choice.

CHINA HERITAGE (4 days 3 nights)Beijing – Xian – Chengdu - BeijingAccommodation, transfers, 1 breakfast, 2 lunches, 1 dinnerPrice per person – € 898 single / € 770 doubleJourney into cities endowed with the magnificence of UNESCO world heritage sites & exhilarating vistas of natural landscapes and wonders as you travel into the cities of Xian and Chengdu. An adventure awaits with the mysterious & glorious finds of the terracotta warriors and the Sanxindui


TOURS

Museum & their historical origins before you embark on charming escapade with the giant pandas at the Panda research base. Culture abounds in both cities where you will be privy to the magnificent mastery of Sichuan face mask changing & tea appreciation which are known to the world.

LOCAL TOURS(all tours require a minimum of 30 pax)

BEIJING’S SPLENDOUR Where heaven, earth & people meet: Tiananmen Square, Forbidden City & Temple of Heaven, with lunchFull Day Tour (8hrs) – € 38 per personRevel in the magnificence, mystery & beauty of Tiananmen Square, Forbidden City and the Temple of Heaven. The splendor and vibrance of Beijing can best be experienced as you are taken on a historic journey beginning with the Tiananmen Square. Translated as the Gate of Heavenly Peace, this is the symbol of the nation. This is where millions flock to have a picture taken to the backdrop of Mao’s portrait. As a gateway to the magnificent spectacle of the Forbidden City, prepare for an awe

inspiring sight of a time honored city of a long history and a sophisticated culture. Home to two dynasties of the Ming and Qing Dynasty, marvel at the glorious artistry and take pleasure in discovering hidden artifacts, interesting history and unique treasure that dot the palace at every corner, courtyard, garden and pavilion that never fails to impress with its character. Your final stop takes you to the Temple of Heaven, a UNESCO world heritage site and the most holy of Beijing’s Imperial temples. The temple depicts in its truest, the emperor’s role which is that of heaven, earth & people as one.

BEIJING’S ARCHITECTURAL MARVELS Through Walls & Tombs: Great Wall and Ming Tombs, with lunchFull Day Tour (8hrs) - € 38 per personTaking you through a vision of greatness through architectural marvels, the day begins with a journey to the Great Wall, one of the greatest wonders of the world and a UNESCO world heritage site. Winding through deserts, grasslands, mountains and plateaus, the wall stretches up to 6,700km and has a history of more than 2000 years. Enjoy the panoramic views of the surrounding as you take the challenge of the climb. Complete the day with a visit to the Ming Tombs, a mausoleum that houses 13 emperors of the Ming Dynasty. The mausoleums have been perfectly preserved and because of its long history, palatial and integrated architecture, the sight provides for a highly historic and cultural experience.

BEIJING’S NATURAL WONDERS Of Solitude, Tranquility and Beauty: Beijing Zoo and Summer Palace, with lunchHalf Day Tour (6hrs) - € 30 per personRelish in the natural wonders of the Beijing Zoo and the Summer Palace where you will be treated to the beauty and tranquility of nature at its best. Starting out at the zoo, the highlight of the visit will no doubt be the giant panda exhibits, amidst the natural beauty of lakes & lush greenery. From the zoo, journey to the Summer Palace where you will truly experience the tranquil elegance of the past as appreciated by the imperial family. Built specifically as a summer retreat for emperors in the Qing Dynasty, it personifies the essence of garden landscaping that reveals the palatial grandeur and elegance that has made it a UNESCO world heritage site. Just the mere names of some of the attractions here - Cloud Dispelling Hall; Buddhist Virtue Temple; Harmonious Interest Garden – are enough to fire your imagination and spirit you back in time.

TOURS

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

BEIJING’S LIVING TREASURESOf courtyards & alleys: Hutong & Prince Gong with Tea Appreciation and lunchHalf Day Tour (4hrs) - € 40 per personHutongs are ancient alleys typical in Beijing, with many built during the Yuan, Ming & Qing Dynasties. Experience the culture & immerse yourself in the spirit of the people as you traverse along a maze of alleys and visit courtyard homes of the locals. From trying your hand at making dumplings to seeing a newly weds bedroom, you will be amazed at the intricate etiquette of the people. Complete the day with a visit to Prince Gong’s mansion, one of the few intact aristocratic residences from the Qing Dynasty. A pride of the venue is its garden named Cuijin which means the “a collection of the most beautiful flowers”. The garden covers 28,000 square meters and is studded with artificial hills, trees, flowers, pavilions, terraces and traditional buildings. Embark on a culturally enriching experience of tea appreciation at the mansions tea house, a truly sophisticated & elegant building.

BEIJING SPECTACULARAt the Beijing Night Show, with dinnerNight Tour (6hrs) - € 48 per personA true definition of China’s artistic talents and cultural richness, embark on a journey of beauty, grace, precision and artistry as the evening’s show takes you from the brilliance of Beijing Opera to the elegance of Chinese dance, the precision and dynamism of acrobatic and kungfu. Combined with a stage set of skillful craftsmanship depicting visions of China with a showcase of exotic costumes, revel in the majestic grandeur of Beijing Night. Sit back and let the evening take you on a journey of exotic discovery through music, dance and acrobatics amidst a lush atmosphere and a tantalising artistic feast.

BEJING LEGEND At the Legend of Kungfu Show & Peking Duck DinnerNight Tour (6hrs) - € 48 per personThe Red Theater presents an amazing theatrical performance, which has been touted as a perfect “an audiovisual feast that combines special effects, martial arts & dance at its best. It is colourful, exciting and dramatic, a combination of raw power,

imaginative theatrics and a strong story line that will leave the audience gasping in wonder.” After an enigmatic and mesmerizing experience of superb talent & skills, sit back and enjoy a sumptuous dinner of great local flavor of Peking Duck.

BEIJIING SHOPPING EXTRAVAGANZALiu Li Chang Street & Silk Market, with lunchHalf Day Tour (4hrs) - € 22 per person

Known as a shoppers paradise, embark on an interesting and exciting shopping extravaganza that will take you to the historic Liu Li Chang and the best known Silk market. Liu Li Chang is characterized by its unique cultural and artistic atmosphere, which has been gradually formed since the mid Qing Dynasty and dating back nearly 200 years. The street now boasts a lot of ancient stores as well as the biggest store of ancient books in Beijing, with the most famous ancient store is Rongbaozhai (Studio of Glorious Treasures). Famous for its collection of calligraphy and paintings that span centuries, Rongbaozhai is now one of the most illustrious traditional art galleries in China. Despite its name, the Silk Market has much more than just silk. The silk products here are cheap, and therefore popular, but there are also a lot of cashmere garments, down jackets, leather goods, shoes, hats, watches and some handicrafts and trinkets. One of the main things about the Silk Market is the fact that none of the prices are set so get ready to test your bargaining skills for some of the best buys.

For more information & reservations, please send an e-mail to: [email protected]


ROOM 10�

09:00 – 12:00* G 3:EVIDENCE BASED PRACTICE AND COMPLEMENTARY MEDICINES: TEACHING AND LEARNING BY EXAMPLE204 – 999 – 07 – 069 – L04FIP Academic Pharmacy SectionFIP Pharmacy Information SectionA facilitated workshop using a structured case study approach to evaluating and using evidence.Learning objectivesAt the conclusion of this session, participants will be able to:- understand a structured approach to asking

answerable clinical questions;- be familiar with tools and strategies for

searching the literature;- have understanding of the principles of critical

appraisal;- understand an educational approach to

becoming an evidence based practitioner.Chair: Gary Smith, University of Maryland, USAEvidence based practice and complementary medicines: Teaching and learning by exampleKirstie Galbraith and Greg Duncan, Monash University, USA

14:00 – 17:00

*G �:IS THERE ENOUGH EVIDENCE FOR THE VALUE OF PHARMACISTS?204 – 999 – 07 – 070 – L04FIP Administrative Pharmacy SectionLearning objectives At the conclusion of this session, participants will be able to:- define the services and benefits that

pharmacists can offer to society;- respond to the challenges of changes in

healthcare;- describe the evidence and the value of

pharmacists to the society;- develop strategies to convince policy makers

of the value of pharmacists. Chairs: Marion Schaefer, Institute for Clinical Pharmacology, Germany and Inka Puumalainen, FinlandHow should we regulate community pharmacy services to achieve optimum outcomes for the society?John Chave, Pharmaceutical Group of the European Union, Belgium Business versus public health orientation in pharmacy: Lessons learnt from regulatory changesAlan Lyles, University of Baltimore, USAHow to convince the decision makers about the value of pharmacists: A need for global initiatives and co-operation – The African perspective Alexander Dodoo, University of GhanaHow to convince the decision makers of the value of pharmacists: A need for global initiatives and co-operation – The Asian perspectiveSpeaker TBA, China Discussion and way forward: Putting the resources together

ROOM 101

09:00 – 12:00* G 11:TRENDS IN COMMUNITY PHARMACY – DEBATING THE FUTURE OF THE PROFESSION: FORUM FOR POLICY MAKERS IN PHARMACY PRACTICE204 – 999 – 07 – 076 – L04FIP Community Pharmacy SectionFIP Young Pharmacists GroupInternational Pharmaceutical Students’ FederationToday, community pharmacists face a number of challenges and opportunities. No matter where in the world community pharmacists are practicing, issues such as pharmacist prescribing (USA: Collaborative practice), deregulation of the pharmacy sector, leadership and succession, and the role of the pharmacist are being discussed. It is crucial to maintain an open debate within the profession, encompassing policy makers and practicing pharmacists as well as future professionals. Target audiencePolicy makers in pharmacy practice; pharmacists working in community pharmacy; young pharmacists and students.FormatModerated session with short interventions by selected member organisations – invited by the FIP Community Pharmacy Section – and young pharmacists and pharmacy students – invited by the FIP Young Pharmacists Group and the International Pharmaceutical Students’ Federation – presenting challenges and views of the topics chosen. Following the interventions, other member countries and individuals have been invited to comment and present their views. Learning objectivesAt the conclusion of this session, participants will be able to:- identify some of the global and regional trends that affect the practice of community pharmacists;- understand issues related to pharmacist prescribing, deregulation of the pharmacy sector, leadership and succession,

and the role of the pharmacist;- acknowledge the different views of the participants: Member organisations, community pharmacists, young

pharmacists and pharmacy students;- describe how pharmacists can be best prepared for changes in pharmacy practice;- describe how pharmacists can seize the opportunities presented by changes in pharmacy practice.Managing Chair: Ema Paulino, FIP Community Pharmacy Section, PortugalCo-Chair: Dick Tromp, Quality Institute for Pharmaceutical Care, The NetherlandsTopic A – Pharmacist prescribing (USA: Collaborative practice)Recently, pharmacists in some countries have seen their role extended with the right to prescribe initial therapy and/or to adjust ongoing therapy. There are challenging opportunities ahead, which will certainly have an impact not only on pharmacists work, but also on public and policymakers’ perception of pharmacists. How should we adapt education and training of pharmacists to meet this new challenge? And what will be the impact of this novel role of the pharmacist on the profession and on the relationship with other health professionals?Keynote speaker: David Pruce, Royal Pharmaceutical Society, United KingdomResponses: Boyan Todorov, FIP Young Pharmacists Group, Bulgaria; Audrey Clarissa, International Pharmaceutical Students’ Federation, Indonesia; Claire Anderson, FIP Academic Pharmacy Section, United KingdomTopic B – Deregulation of pharmacy In the past few years, many countries have seen the liberalisation of community pharmacy ownership and establishment. Some countries, however, have introduced regulations, while, in others, such regulations have never existed. How does regulation/deregulation of community pharmacies affect the profession and the way young pharmacists and students perceive their future as community pharmacists? What image and impression of community pharmacists and pharmacies does deregulation portray to the public?Keynote speaker: Patrick Reid, Pharmacy Guild, Australia Responses: Rai Vaidya, Hindu Pharmacy Goa, India; Katja Hakkarainen, International Pharmaceutical Students’ Federation, Finland; Ingunn Björnsdóttir, Danish University of Pharmaceutical Sciences, DenmarkTopic C – Leadership and succession – Preparing the next generation of community pharmacists Young pharmacists and pharmacy students should be recognised as professionals rather than viewed as an unavoidable future. In this section, we will look at the qualities desired in a community pharmacist, the role of pharmacy education, experiential training and other opportunities (e.g. involvement in professional and student organisations) in shaping the future leaders of the community pharmacy workforce and, finally, we will look at existing models of succession in various countries. Keynote speaker: Tana Wuliji, FIP Young Pharmacists’ Group, New Zealand Responses: Warren Meek, FIP Community Pharmacy Section, Canada; Zhining Goh, International Pharmaceutical Students’ Federation, Singapore; Billy Futter, Rhodes University, South AfricaTopic D – The community pharmacist - The forgotten healthcare team member? What is the role of community pharmacists in multidisciplinary healthcare teams? This part of the session aims to discuss the lack of awareness of and recognition for community pharmacists by the public, other sectors of the profession and fellow healthcare professionals. But more than acknowledge this lack of awareness, how can we face it and ensure that the potential of community pharmacists is maximised effectively for the best of primary healthcare?Keynote speaker: Karen McGill, International Pharmaceutical Students’ Federation, USAResponses: Dominique Jordan, FIP Community Pharmacy Section, Switzerland; Gisselle Gallego, FIP Young Pharmacists’ Group, Australia

14:00 – 17:00G 12:STEERING COMMITTEE MEETINGFIP Community Pharmacy SectionManaging Chair: Martine Chauvé, FIP Community Pharmacy Section, FranceSession targeted at official delegates of the Member Organisations and at individual members and observers.

TUESDAY � SEPTEMBER 2007


ROOM 102

09:00 – 12:00S 3:IMPROVING BIOAVAILABILITY/BIOEqUIVALENCEFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Bioavailability/BioequivalenceChairs: Zhang Qiang, Peking University, China and Shinji Yamashita, Japan Techniques to improve bioavailabilityWilliam Charman, Monash University, Australia Influence on bioavailability/bioequivalence using nanotechnology formulations Zhang Qiang, Peking University, ChinaPhysiological based PK modeling – Application to decision making in biopharmaceuticals Gertrud Ahr, Bayer HealthCare, GermanyIn vitro ADME studies Shinji Yamashita, Japan

14:00 – 17:00S �:BIOTECHNOLOGYFIP Board of Pharmaceutical SciencesFIP Special Interest Group on BiotechnologyChairs: Wayne Gombotz, Omeros Corporation, USA and Fang Hu, Shanghai Sunway Biotech Co. Ltd., ChinaTargeted drug discovery Shigeki Sasaki, Kyushu University, Japan Manufacturing of biotech products, e.g. monoclonal antibodies and vaccines Wayne Gombotz, Omeros Corporation, USA Manipulation of gene structure for targeting tumors Fang Hu, Shanghai Sunway Biotech Co. Ltd., ChinaIssues in dealing with biosimilar productsRoger Williams, United States Pharmacopeia, USA

ROOM 106

09:00 – 12:00* G 19:CLINICAL TRIALS IN ASIA204 – 999 – 07 – 081 – L01FIP Hospital Pharmacy SectionFIP Industrial Pharmacy SectionClinical development is a lengthy and costly process and reducing development time and cost, while maintaining the quality of data, is a constant challenge for drug developers. Asia, and particularly China, increasingly emerges as a destination for conducting clinical trials. The objective of this symposium is to give an insight in several regulatory, logistic and cultural fundamentals of conducting clinical trials and to make a comparison between trial execution in China versus the rest of the world.Learning objectivesAt the conclusion of this session, participants will:- have an understanding of the organisation of

trials in Asia;- be able to compare with trials in USA/Europe;- be able to apply the learning to their practice.Chairs: Claudia Rijcken, N.V. Organon, The Netherlands and Toby Clark, Medical University of South Carolina, USAThe role of the pharmacist in clinical trials in Chinese hospital pharmacyLiyan Miao, Hospital of Soochow University, China Clinical trials experience in Japan and other Asian countriesJunichi Kawakamim, Hamamatsu University School of Medicine, JapanGCP interpretation in China: A comparison to the FDA interpretationJiaqi Xu, State Food & Drug Administration (SFDA), ChinaOutsourcing Preclinical & Clinical R&D to ChinaQing-An Jiao, MDS Pharmaservices Inc., ChinaClinical trials in the USA: A comparison with AsiaJill Martin, University of Cincinnati, USAPanel discussion

12:30 – 13:30FLU PANDEMIC PROGRAMME (PART I)Over the last several years, pandemics have become an ever-increasing threat to global health, most notably those caused by rampant and extremely contagious viral infections. These symposia will focus on the latest in anti-virals being used to combat and curb the spread of such diseases, as well as how pharmacists and the profession as a whole may best be prepared to effectively detect those infections of pandemic potential, and be active in their control. This session will continue on Wednesday, 12:30 to 13:30 in room 106.Topic 1: The viral and epidemiology perspectives for Avian FluTopic 2: Preparing the pharmacy profession for pandemics

14:00 – 17:00G 20:COMPLEMENTARY & ALTERNATIVE MEDICINES WORKSHOP (PART I)FIPWorld Health Organization

ROOM 107

09:00 – 12:00* G 27:CUSTOMER RELATIONSHIPS (PART I)204 – 999 – 07 – 084 – L04FIP Community Pharmacy SectionHow do you create a level of customer satisfaction so strong that customers become your best sales people? The answer lies in generating a customer experience so distinctive and valuable that it commands not just customer satisfaction but customer loyalty. Companies with satisfied, loyal customers enjoy higher margins and greater profits than businesses that fail to satisfy and retain their customers. Loyal customers and customer experience are also important topics for pharmacy. Brands take their value from customer perception. In order to remain valuable, they must provide a customer experience that is valuable to the customer. This is a crucial task for tomorrow’s pharmacy managers.This topic was introduced in a keynote lecture at the Steering Committee Meeting in Salvador Bahia 2006. In Beijing 2007, we follow up with a full-day programme giving more in-depth knowledge and experience.Target audiencePolicy makers in pharmacy practice, pharmacists working in community pharmacy and/or with business development.Learning objectivesAt the conclusion of this session, participants will be able to:- understand the need of strong customer relationships, and understand how

to, consistently and intentionally, deliver on the brand promise in a way that creates competitive differentiation and significant value for the target customer;

- understand strengths and weaknesses regarding the medicines management process;

- understand key issues and critical success factors regarding the medicines management process;

- understand how the medicines management process can be improved by use of internationally adopted control frameworks;

- learn from ‘best practice’ cases around the world.Managing Chair: Prafull Sheth, South East Asia Regional Forum, IndiaCo-Chair: Hanne Herborg, Pharmakon, DenmarkCustomer relationshipsLars-Åke Söderlund, Apoteket AB, Sweden Outline: Companies need to turn their customers into advocates, and do so by delivering a branded customer experience. Accordingly, the customer must indeed be at the heart of the strategy of any service company. How to deliver breakthrough value, by re-inventing customer and employee experienceLars-Åke Söderlund, Apoteket AB, Sweden Outline: Achieving breakthrough value requires strategic leadership/management and careful planning based on a comprehensive understanding of customer needs and behaviour. This implies delivering a differentiated customer experience, lowering costs by staffing with the right people at the right time, and maximising the return from strong customer relationships. A memorable customer experience can be said to be consistent, intentional, differentiated and delivering value. This can be achieved by focusing on values and culture, vision and strategy. This session outlines how pharmacy leaders/management can strive to deliver breakthrough value to employees, customers and other stakeholders.

14:00 – 17:00* G 28:CUSTOMER RELATIONSHIPS (PART II)204 – 999 – 07 – 085 – L04FIP Community Pharmacy Section(continued from morning session)Breakthrough value for third party payers by working with the medicines management process from an audit perspectiveSven Hedlund, Apoteket AB, SwedenOutline: This involves working with the control environment, risk assessment, learning and development, control activities, information and communication, monitoring and development regarding the medicines management process, to identify where in the process all the gaps are.Only then will it become clear how pharmacy and pharmacists can contribute to improved drug use. When customers become aware of their problems, they are more likely to see the need for support from pharmacy. Golden pearls – Short presentations from invited countries This session is on evidence-based and value-based results as a lever for breakthrough value regarding medicines management. There will be examples from integrated pharmacy systems and community pharmacy as a resource for improved health and cooperatives for learning and development.Panel discussion

TUESDAY � SEPTEMBER 2007


ROOM 90

09:00 – 12:00* G 35:EVOLUTION OF PRACTICES IN CLINICAL BIOLOG204 – 999 – 07 – 090 – L01FIP Clinical Biology SectionThis session is aimed at tackling several evolutions of clinical biology practices, regarding pharmacogenetics, malaria, renal diseases and biomarkers for allergic children management.Learning objective- to update participants’ knowledge of evolving fields in

clinical biology:* impact of pharmacogenetics on medical practice;* evolution of malaria and resistance to the treatment in

Senegal;* renal failures and biomarkers;* biomarkers for allergic children management.

Chair: Bernard Poggi, Hospices Civils de Lyon, FrancePharmacogenetics and medical practiceGeneviève Durand, Hôpital Bichat, FranceMalaria in Senegal: Biological diagnosis and future prospects about treatmentMarie-Claude Sene, Pharmacie Mourtalla Mbacke Fallilou, SenegalRenal failures and laboratory medicine: Biomarkers for screening campaigns and for patient managementFrançois Trivin, Hôpital Saint Joseph, FranceLaboratory medicine biomarkers for allergic children managementLayachi Chabraoui, Société Marocaine de Chimie Clinique (SMCC), Morocco

14:00 – 17:00G 36:NANOTECHNOLOGY – FROM SCIENCE TO INDUSTRIAL PRACTICEFIP Industrial Pharmacy SectionChairs: Tom Sam, N.V. Organon, The Netherlands and Wan-Liang Lu, Peking University, ChinaLearning objectiveAt the conclusion of this session, participants will be able to:- appreciate the challenges of the development of medicinal

nanotechnology and its applications in an industrial setting.Advances in nanotechnology: Research and applications in the Chinese pharmaceutical industryWan-Liang Lu, Peking University, ChinaPeptide-functionalised nanocarriers with improved membrane permeation properties to facilitate site-directed drug deliveryGiovanni Pauletti, University of Cincinnati Medical Center, USAIndustrial nanomanufacturing of drug delivery systemsYoshiaki Kawashima, Aichi Gakuin University, Japan (invited)Regulatory aspects of nanotechnologyGuo-Zhong Rui, China Center for Pharmaceutical International Exchange of SFDA, China (invited)

Announcement

World Congress of Pharmacy

and Pharmaceutical Sciences 2008

68th International Congress of FIP

Basel, Switzerland29 August until 4 September 2008

www.fip.org/basel2008


programme updates:



ROOM 103

09:00 – 12:00* P 3:TECHNICAL, SCIENTIFIC AND EVIDENCE-BASED INFORMATION RESOURCES ABOUT MEDICINES204 – 999 – 07 – 065 – L04FIP Board of Pharmaceutical PracticeMuch of conventional medicine has been based on the scientific method, with an emphasis on randomised clinical trials as evidence. In contrast, there has been more emphasis on experience over long periods of time as evidence to support the use of complementary & alternative medicines. Is one approach better than the other? If there is less scientific evaluation of complementary & alternative medicines, how do clinicians find information and evaluate these products? This session will address these questions.Learning objectivesAt the conclusion of this session, participants will be able to:- identify resources used by healthcare professionals to find information about both

conventional, and complementary & alternative medicines;- understand issues related to the quality of information about the efficacy of both

conventional, and complementary & alternative medicines;- list sources of information about the safety of both conventional, and

complementary & alternative medicines;- describe how pharmacists can use information about both conventional, and

complementary & alternative medicines to help patients make the best use of them.

Managing Chair: Han de Gier, FIP BPP Programme Committee, The NetherlandsCo-Chair: Zhu Zhu, Peking Union Medical College Hospital, ChinaA review of drug information resources for use by health professionalsLana Dvorkin, Massachusetts College of Pharmacy and Health Sciences, USAWhat is the quality of information about efficacy?Graeme Vernon, Austin Health Drug Information, AustraliaWhere can information be found about safety?Peter de Smet, Royal Dutch Pharmaceutical Society (KNMP – WINAP), The NetherlandsHow can pharmacists provide information and educate patients about efficacy and safety?Alexander Dodoo, Centre for Tropical Pharmacology & Therapeutics, Ghana

14:00 – 17:00* P �:FUTURE ISSUES WITH CONVENTIONAL, AND COMPLEMENTARY & ALTERNATIVE MEDICINES204 – 999 – 07 – 066 – L04FIP Board of Pharmaceutical PracticeAs cultures become less isolated, in the future there will be a need to evaluate, and perhaps accommodate the practices in each culture, including the use of medicines. Some of the social issues that arise include harmonisation of different types of medicines, reimbursement policies that were originally developed with one type of medicine, and the rising concern about affordability and access to healthcare. This symposium will address these issues.Learning objectivesAt the conclusion of this session, participants will be able to:- express an opinion about integrating complementary & alternative medicines with

conventional medicines;- describe issues related to the policy of health insurance coverage for

complementary & alternative medicines in the future;- list what factors can ensure the safety and use of complementary & alternative

medicines and how this can be improved in the future;- discuss the impact of access and affordability of healthcare on the future use of

complementary & alternative medicines.Managing Chair: Robert DeChristoforo, FIP BPP Programme Committee, USACo-Chair: Zuguang Ye, China Academy of Traditional Chinese Medicine, ChinaHow can complementary & alternative medicines co-exist with conventional medicines? Laura Shane-McWorther, University of Utah, USAWho will pay for complementary & alternative medicines? David Henry, Newcastle University, AustraliaHow can the safety and use of complementary & alternative medicines be improved?Zuguang Ye, China Academy of Traditional Chinese Medicine, ChinaSocial, economic and public policy issues and the future use of complementary & alternative medicinesTorkel Falkenberg, Karolinska Institute, Sweden

ROOM 101

09:00 – 12:00G 13:PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM I – PART I)FIP Community Pharmacy SectionShort oral presentations and poster exhibitions are long-standing traditions within the FIP Community Pharmacy Section. The number of submitted abstracts has been ever-increasing in the past few years. Submissions include many abstracts of high quality and, in order to create space for more oral presentations and for discussions on specific topics, the Practitioners’ Day is being launched. Congress participants are invited to submit abstracts for short oral presentation within the four topics specified below. Among the abstracts received, a number will be selected for presentation, while those not selected will be offered poster presentation. FormatThere will be four Forums, two running in parallel in the morning, and two in parallel in the afternoon. Each Forum will be chaired by two facilitators whose task it will be to encourage participants to interactively exchange views. All facilitators are members of the Executive Committee of the FIP Community Pharmacy Section.Target audiencePharmacists working in community pharmacy; policy makers in pharmacy practice; young pharmacists, students and educators.Learning objectivesThis session aims to:- provide a forum in which practitioners and other interested partners can present

their experiences, and expand and share their knowledge of topics relevant to community pharmacy practice;

- promote networking between community pharmacists and other partners interested in community pharmacy practice.

Poster sessionAs always, the FIP Community Pharmacy Section invites for contributions to the Poster session. We welcome Congress participants’ abstracts for poster presentation, not only on the topics mentioned hereafter, but also on other topics of relevance to community pharmacy.A jury appointed by the Executive Committee of the FIP Community Pharmacy Section will select the best poster(s) for an award.Themes of the four Forums 1. Innovative ways of collaboration between community pharmacists and GP’s2. Experiences with patient profiles3. Counterfeit medicines4. The role of the pharmacist in public healthTheme of Forum:1) Innovative ways of collaboration between community pharmacists and GP’sSpeakers TBA, based on submitted abstractsFacilitators: Patti Payne, FIP Community Pharmacy Section, Australia and Dominique Jordan, FIP Community Pharmacy Section, Switzerland

14:00 – 17:00G 1�:PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM I - PART II)FIP Community Pharmacy Section(continued from morning session)Theme of Forum:2) Experiences with patient profilesSpeakers TBA, based on submitted abstractsFacilitators: Patti Payne, FIP Community Pharmacy Section, Australia and Dominique Jordan, FIP Community Pharmacy Section, Switzerland

WEDNESDAY � SEPTEMBER 2007


programme updates:



ROOM 10�

09:00 – 12:00G �:SHORT ORAL PRESENTATIONSFIP Academic Pharmacy SectionLearning objective- to disseminate and discuss research

about pharmacy education.Chair: Ronnie Hansson, Uppsala University, SwedenSpeakers TBA, awaiting abstract submission

14:00 – 17:00* G 6:STRENGTHENING THE REPONSIBLE SELF CARE OF PATIENTS204 – 999 – 07 – 071 – L04FIP Administrative Pharmacy SectionLearning objectivesAt the conclusion of this session, participants will be able to:- understand the opportunities and

limitations of self care;- describe what is meant by responsible

self care;- discuss new indications and

challenges of self care;- define the role of the pharmacist in

self care. Chair: Marion Schaefer, Institute for Clinical Pharmacology, GermanyPatient self care – Opportunities and limitationsLembit Rägo, World Health Organization, SwitzerlandNew indications for self care and increased opportunities for pharmacists Hans Regenauer, Boerhinger Ingelheim, GermanySelf care of pain – What has changed?Bernd Eberwein, BAH (German Manufacturers’ Association), Germany Pharmacists training in self careDavid Webber, World Self-Medication Industry, France Round table discussion: The future of responsible patient self care

ROOM 102

09:00 – 12:00S �:qUALITY CONTROL FOR NATURAL PRODUCTSFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Natural SubstancesChairs: Carmen Tamayo, Flora Inc., USA and De-An Guo, Shanghai Research Center for TCM Modernisation, ChinaMonographs of plants and their preparations in the European Pharmacopeia Heinz Stumpf, GermanyQuality control of natural products De-An Guo, Shanghai Research Center for TCM Modernisation, China Characterisation of natural products: Chemical or biologicalCarmen Tamayo, Flora Inc., USASelection of botanical bioavailability markers based on in silico descriptions and their correlation to in vivo permeabilitySalomon Stavchansky, University of Texas, USA

14:00 – 17:00S 6:RESEARCH IN NATURAL PRODUCTSFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Natural SubstancesThe mission of SIG Natural Substances has continued to be to provide, world-wide, a neutral and independent platform for discussions on natural substances, i.e. herbal medicine, traditional medicine and folk medicine, related to pharmaceutical sciences. In many respects, natural products are the most important and interesting research area: their structures are often extremely complex, and their marked physiological action makes them of great importance in medicine. A number of structurally and also biologically interesting compounds are still being isolated from nature. The recent research works regarding natural products will be discussed in this SIG symposium.Learning objectives- promotion of the pharmaceutical sciences relevant to the study of

natural substances, especially chemistry, applied pharmacology and analysis;

- education of pharmacists in research developments related to drug discovery from natural sources, chemistry of natural products and chemistry, pharmacology and interactions of natural extracts used in pharmacy.

Chairs: Kiyoshi Tomioka, Kyoto University, Japan and Jin Shanghong, ChinaIsolation of active ingredients from natural products Zhongmei Zou, Natural Medicine Research Center, ChinaDevelopment of new drugs from natural products Elizabeth Williamson, University of Reading, United KingdomHow to control side effects of Traditional Chinese Medicine Jin Shanghong, ChinaTotal synthesis of active compounds in natural products Toshio Honda, Hoshi University, Japan

ROOM 106

09:00 – 12:00G 21:PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS ( FORUM II - PART I)FIP Community Pharmacy SectionParallel session, for details: ROOM 101Theme of Forum:3) Counterfeit medicinesSpeakers TBA, based on submitted abstractsFacilitators: Samira Goussous, FIP Community Pharmacy Section, Jordan, and Eugene Lutz, FIP Community Pharmacy Section, USA

12:30 – 13:30FLU PANDEMIC PROGRAMME (PART II)Topic 3: The latest understanding of the H5N1 virus – Innovative anti-virals treatment optionsTopic 4: The preventive role of pharmacists in early detection of Avian Flu

14:00 – 17:00G 22:PRACTITIONERS’ DAY – SHORT ORAL PRESENTATIONS (FORUM II - PART II)FIP Community Pharmacy SectionParallel session, for details: ROOM 101(continued from morning session)Theme of Forum:4) The role of the pharmacist in public healthSpeakers TBA, based on submitted abstractsFacilitators: Samira Goussous, FIP Community Pharmacy Section, Jordan, and Eugene Lutz, FIP Community Pharmacy Section, USA

ROOM 107

09:00 – 12:00* G 29:MEDICATION REVIEWS – FROM MEDICATION COUNSELLING TOWARDS SERVICE DELIVERY204 – 999 – 07 – 086 – L04FIP Pharmacy Information SectionInternational Pharmaceutical Students’ FederationThis three-hour joint session will explore the concept and value of medication reviews as a pharmaceutical service in healthcare. Issues such as the models and status of medication reviews in different countries, the challenges faced in the implementation of medication reviews in healthcare, required competencies and training as well as the impact of medication reviews on drug therapies and healthcare partnerships will be discussed. The session is targeted at individuals and key stakeholders involved in the design and implementation of professional pharmacy and pharmaceutical services.Learning objectivesAt the conclusion of this session, participants will be able to:- define a medication review as a pharmacist-provided service;- recognise the need for medication reviews;- describe different medication review service models;- illustrate how medication reviews can be integrated into health systems;- evaluate how medication reviews can improve health systems and quality/rational use of medicines;- discuss the required education and competences for conducting medication reviews;- discuss the role of pharmacy students in the integration of medication reviews and other professional pharmaceutical services into healthcare.Chairs: Marja Airaksinen, University of Helsinki, Finland and Zhining Goh, International Pharmaceutical Students’ Federation, Singapore Introduction: From medication counselling towards service deliveryMarja Airaksinen, University of Helsinki, FinlandZhining Goh, IPSF, Singapore Medication review - The philosophy and conceptsTimothy Chen, University of Sydney, AustraliaMedication review service models and current status in different countriesKatja Hakkarainen, University of Helsinki, FinlandImplementation and integration of medication reviews into healthcare systemsShalom ‘Charlie’ Benrimoj, University of Sydney, AustraliaCompetences required for conducting medication reviewsLea Tuomainen, University of Kuopio, FinlandThe evidence of the impact of medication reviews on outcomes of drug therapyAlan Lyles, University of Baltimore, USA

14:00 – 17:00* G 30:GOOD VERSUS BAD DRUG INFORMATION IN THE PUBLIC DOMAIN – CAN YOU SPOT THE DIFFERENCE?Empowering pharmacists and educating patients how to use online information204 – 999 – 07 – 087 – L04FIP Pharmacy Information SectionFIP Young Pharmacists GroupDrug information in the public domain impacts various aspects of medicines use and patient safety. The “good” information empowers the patients to become an active partner in their therapy. However, the incomplete or improper use of medication information can have dramatic effects. But how is good or bad drug information defined and what is the role of the pharmacist in helping patients to make informed decisions based on such information?The abundance of online medication information poses new challenges for both patients and healthcare professionals. How can information be appropriate, complete, correct, and at the same time on accessible level to the patient? Can pharmacists educate patients how to use online information?The medication information from various online sources influences also the pharmacy profession. In education various sources on Internet will influence the students’ opinions about safe and effective use of medicines. As medicines experts who can assist consumers’ medicines information needs, pharmacists need to be able learn how to search for and evaluate Internet-based information themselves.In their practice, there is an increased demand for objective interpretation of the available medicines information. But how are professionals providing pharmaceutical care at the drug information centres influenced by publicly available drug information?Target audiencePharmacists working in the hospital, community, and drug information centres as well as young pharmacists and students, and educators.Learning objectivesAt the conclusion of this session, participants will be able to:- identify the challenges posed by the abundance of medication information sources in the public domain;- understand the various techniques to assess the quality of drug information sources in the public domain;- acknowledge the need for evaluation of online information as part of pharmacist drug information literature search;- describe roles of the pharmacist in establishing standards to educate the public in deciding on the use of drug information from various sources;- learn the various methods which have been shown to be effective in communicating proper use of drug information on the Internet.Chairs: Boyan Todorov, FIP Young Pharmacists Group, Bulgaria and Alexander Dodoo, University of Ghana Medical School, GhanaThe need for quality assurance in medicinal information in the public domainGerald McEvoy, American Society of Health-System Pharmacists, USA How patients use online informationGeraldine Peterson-Clark, Boehringer-Ingelheim, AustraliaTeaching pharmacy students how to search for, analyse, and utilise Internet-based medicines information Gary Smith, University of Maryland, USA Online information as part of pharmacist drug information literature searchEllen Diedrichsen, Massachusetts General Hospital, USAPanel discussion (breakout groups)- Are we doing enough to ensure online information is used adequately?- What are the roles of the pharmacists in validating the online information?- Are pharmacists prepared to educate patients how to use available medicinal information?


WEDNESDAY � SEPTEMBER 2007

ROOM 10�

09:00 – 12:00 * G 7:THE ASIAN DRUG MARKET – CURRENT TOPICS AND CHALLENGES204 – 999 – 07 – 072 – L04FIP Administrative Pharmacy SectionLearning objectivesAt the conclusion of this session, participants will be able to:- understand the specific situation of the Asian pharmaceutical market;- address the challenges of change in this region;- understand specific issues of the generic drugs industry and pharmacovigilance;- describe and understand strategies of growth in the Asian pharmaceutical market.Chairs: Albert Wertheimer, USA and Gordon Geddes, USAThe generic drugs industry in China Ting-Xi Hu, China Pharmaceutical University, China Pharmacovigilance in ChinaYi Xin Chen, Chinese Governement, China Drug patents and their impact on the Asian pharmaceutical market Rong Shao, China Pharmaceutical University, China Round table discussion: The Asian pharmaceutical market – Strategies of growth

14:00 – 17:00* G 8:THE CHALLENGES OF DIABETES IN ASIA204 – 999 – 07 – 073 – L01FIP Administrative Pharmacy SectionLearning objectivesAt the conclusion of this session, participants will be able to:- understand health care problems arising from diabetes in Asia and other

developing countries;- evaluate methods for the cost benefit analysis of diabetes treatment;- address the main issues of diabetes care from the perspective of health policy;- discuss strategies for improving diabetes care in developing countries. Chair: Albert Wertheimer, USA The epidemiology of diabetes, treatment guidelines and consumption of anti-diabetics in AsiaSpeaker TBA, China Cost-effectiveness analyses in diabetes: The CORE Diabetes ModelAndrew Palmer, IMS Health, China Decision making for diabetes care for the health policy perspectiveBram Hartzema, University of Florida, USA (invited) Round table discussion: Improving healthcare for diabetes – Is it affordable?

ROOM 90

09:00 – 12:00G 37:SHORT ORAL PRESENTATIONS (PART I): MANUFACTURING AND GOOD MANUFACTURING PRACTICEFIP Industrial Pharmacy SectionIndustrial pharmacists and scientists will give short oral contributions on a challenging problem related to manufacturing or GMP. Each presenter will deliver his/her contribution in an interactive way, discussing the topic directly with the audience and/or with members of the expert panel.Learning objective- Industrial pharmacy encompasses many disciplines, and the objective of this

session is to create enhanced understanding of the topic both with the presenter and the audience.

Chair: Adel Sakr, University of Cincinnati, USACo-Chairs: Qiang Zhang, Peking University and Wenfang Xu, Shandong University, China

14:00 – 17:00G 38:SHORT ORAL PRESENTATIONS (PART II):DRUG DELIVERYFIP Industrial Pharmacy SectionIndustrial pharmacists and scientists will give short oral contributions on a challenging problem related to drug delivery. Each presenter will deliver his/her contribution in an interactive way, discussing the topic directly with the audience and/or with members of the expert panel.Learning objective- Industrial pharmacy encompasses many disciplines, and the objective of this

session is to create enhanced understanding of the topic both with the presenter and the audience.

Chair: Adel Sakr, University of Cincinnati, USACo-Chairs: Guoan Luo, Tsinghua University and Zhirong Zhang, Sichuan University, China


THURSDAY 6 SEPTEMBER 2007

ROOM 101

09:00 – 12:30* G 1�:CONTINUING EDUCATION PROGRAMME:FROM RESEARCH TO DAILY PRACTICE – IMPLEMENTING “FAMILY PHARMACY” – AN INNOVATIVE STRATEGY AND BUSINESS MODEL (PART I)204 – 999 – 07 – 077 – L04FIP Community Pharmacy SectionIn future, it is imperative that pharmacies develop strong strategies and innovative business models to maintain control of the quality of pharmaceuticals with respect to their safe and efficient availability to patients. Research demonstrates its added value in bringing scientific evidence, applicable workflow methods and quality management standards into practice – easy to know, but so difficult to do. This is why, in Beijing, this one-day Continuing Education Programme will focus mainly on the implementation of innovative research projects into the daily practice of community pharmacies.This Continuing Education Programme focuses on the “Family Pharmacy” model. Its originality is the combination of remunerated advanced services in a context of increasing deregulation and cost containment driving forces. In Germany, for instance, “Family Pharmacy” includes remuneration for pharmaceutical care (drug profiles, medication reviews, counselling, medication reports), starting with the indication asthma/chronic obstructive pulmonary disease services. The aim is to optimise patient care in a cost-effective manner via improved therapeutic outcomes and improved medication safety. Under this programme, patients select their “family pharmacy” from a list of participating community pharmacies and use their selected pharmacy for a set term, usually at least one year. Consequently, all medicine, both prescription-only and OTC, supplements and devices are delivered by this pharmacy. To qualify for the programme, pharmacists must complete a one-day, certified education programme. In addition, there are specific requirements relating to the pharmacy itself, e.g. the availability of the appropriate computer software.By providing concrete information, management and education resources, this Continuing Education Programme will give participants an opportunity to discuss and work with a number of practice models in the context of their own experience, culture and national environment.Target audiencePharmacists working in community pharmacy, young pharmacists, students and educators.Continuing Education Programme: Separate registrationSeparate registration is required and is only possible in addition to a full Congress registration. Deadline for registration is 1 August 2007.Learning objectivesAt the conclusion of this session, participants will be able to:- outline the strategies and actions needed of national associations and individual pharmacists to promote the added value of

community pharmacists versus alternative, deregulated drug supply chains;- describe the concept of the “Family Pharmacy” model is and outline the strategies for its development;- utilise the information, education and management resources provided to facilitate the dissemination and implementation of

“Family Pharmacy” models;- contrast the barriers and facilitators influencing the implementation of “Family Pharmacy” models in various countries;- understand the benefits of a close partnership between practitioners and practice research groups.Managing Chair: Olivier Bugnon, Policlinique Médical Universitaire of Lausanne, Switzerland Planning Committee: Olivier Bugnon, Policlinique Médical Universitaire of Lausanne, Switzerland (Chair); Hanne Herborg, Pharmakon, Denmark; James McElnay, The Queen’s University of Belfast, United Kingdom; Alison Roberts, University of Sydney, Australia; Martin Schulz, Bundesvereinigung Deutscher Apothekerverbände (ABDA), Germany Welcome and introductionOlivier Bugnon, Policlinique Médical Universitaire of Lausanne, Switzerland “Family Pharmacy” – The three essential elements of the practice model development: Evidence from research, conceptual framework and strategyMartin Schulz, ABDA, GermanyComments, experiences, barriers and facilitators Short presentations from invited countriesWorkshop 1: Work together or perish!This discussion workshop will look for solutions to overcome the traditional issues that any implementation process faces. The “Family Pharmacy” model will be used as an example to explore the possible answers to these questions: - How to work together to make “Family Pharmacy” happen;- How to prevent or minimise the risks related to the implementation process;- How to motivate the pharmacy team and the patients/customers to participate.

14:00 – 17:00* G 16:CONTINUING EDUCATION PROGRAMME:FROM RESEARCH TO DAILY PRACTICE – IMPLEMENTING “FAMILY PHARMACY” – AN INNOVATIVE STRATEGY AND BUSINESS MODEL (PART II)204 – 999 – 07 – 078 – L04FIP Community Pharmacy Section(continued from morning session)Workshop 2: “Family Pharmacy” – How to do it! Based on the illustration of the experiences in Germany with the implementation of the “Family Pharmacist” model, participants will contrast the presented model with the evidence given in scientific literature and with their own experiences, culture and environment.“Family Pharmacy” – Testimony of a German community pharmacistFriedemann Schmidt, Fontane-Apotheke Leipzig, Germany Summary and closureJames McElnay, The Queen’s University of Belfast, United Kingdom

ROOM 102

09:00 – 12:00S 7:IMPACT OF INDIVIDUALISED MEDICINE IN PHARMACEUTICAL CAREFIP Board of Pharmaceutical SciencesFIP Special Interest Group on Individualised MedicineChairs: Hitoshi Sasaki, Nagasaki University, Japan and Anke-Hilse Maitland-Van der Zee, Utrecht University, The NetherlandsIntroduction: Topics of Individualised MedicineHitoshi Sasaki, Nagasaki University, JapanLecture title TBAWeimin Cai, Shanghai Jiao Tong University School of Medicine, ChinaClinical approach for pharmaceutical care in individualised medicine Toshiyuki Sakaeda, JapanPrinciple of individualised medicine for pharmacists CK Shim, South Korea (invited)Ethical considerations, cost effectiveness and regulationsBert Leufkens, The NetherlandsConclusions Anke-Hilse Maitland-Van der Zee, Utrecht University, The Netherlands

14:00 – 17:00S 8:FROM KNOWLEDGE TO CONTROLLING: MEDICINAL CHEMISTRY BASED ON CHEMICAL BIOLOGYFIP Board of Pharmaceutical SciencesPharmaceutical Society of Japan (PSJ)Chairs: Nobutaka Fujii, Kyoto University, Japan and Zhu-Jun Yao, Shanghai Institute of Organic Chemistry, China Where are we going? The future of drug discovery in the 21st centuryDavid Triggle, State University of New York - Buffalo, USA Study of novel parasitic agents, antimalaria, antileishmaniasis and antitrypanosomasisMasataka Ihara, Hoshi University, JapanTotal synthesis and chemical biology of bioactive natural products and drug-like moleculesZhu-Jun Yao, Shanghai Institute of Organic Chemistry, ChinaFrom Amino Acids to Peptide Isosteres: Implication to Genome-lead drug discovery using Peptide-lead drug templatesNobutaka Fujii, Kyoto University, Japan

WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES2�

THURSDAY 6 SEPTEMBER 2007


programme updates:


ROOM 106

09:00 – 12:00G 23:COMPLEMENTARY & ALTERNATIVE MEDICINES WORKSHOP (PART II)FIPWorld Health Organization

14:00 – 17:00G 2�:GOOD MANUFACTURING PRACTICE (GMP) & GOOD COMPOUNDING PRACTICE (GCP)FIP Board of Pharmaceutical SciencesFIP Industrial Pharmacy SectionChairs: Feng Yi, State Food and Drug Administration, China and Mukund Yelvigi, Wyeth, USAImplementation of GMP Speaker TBA, State Food and Drug Administration, China GMP practice in Europe Tom Sam, N.V. Organon, The NetherlandsPanel discussion GCP practice in multi-center studies Feng Yi, State Food and Drug Administration, ChinaGCP practice in the USA Sampat Singhvi, Bristol Myers Squibb, USA

ROOM 107

09:00 – 12:00* G 31:THE USE OF INFORMATICS TO IMPROVE MEDICATION SAFETY204 – 999 – 07 – 088 – L04FIP Hospital Pharmacy SectionFIP Pharmacy Information SectionFIP Community Pharmacy Section The safe use of medicines depends on many factors, such as safe storage, safe prescribing, safe dispensing, safe administering and counseling. Various techniques have been developed to improve and support these practices. The use of informatics has been identified as a crucial component in improving medication safety. This session will evaluate the various techniques, describe the importance of risk assessment tools, and offer some valuable insight from projects where effective use of informatics has made a significant contribution to safe use of medicines.Target audiencePharmacists working in the hospital, in community, in the military, or in the pharmaceutical industry; young pharmacists, students and educators.Learning objectivesAt the conclusion of this session, participants will be able to:- describe various information and communication techniques to

support the safe use of medicines;- explain the role of the pharmacist in establishing standards to

achieve medication safety; - list the various methods which have shown to be effective in

improving medication safety, within the health care chain (such as seamless care);

- discuss the usefulness of the various tools for the practice change;

- discuss the role of the patient in using ICT for the safe use of medicines.

Chairs: Graeme Vernon, Austin Hospital, Australia; Ema Paulino, FIP Community Pharmacy Section, Portugal; Marianne Ivey, Health Alliance Pharmacy Services, USAOverview of ICT techniques to support the safe use of medicinesBill Felkey, Auburn University, USA (invited) The information sources to be used in ICT supported medication surveillanceHenk Buurma, Stevenshof Pharmacy SIR, The Netherlands Identifying and reducing medication errors: Findings from a national programmeJohn Santell, United States Pharmacopeia, USAAchievements in hospital pharmacy: What worksNick Barber, University of London, United KingdomAchievements in community pharmacy: Lessons learntSandra Lino, Associaçao Nacional das Farmacias, Portugal The role of the patient in using ICT for the safe use of medicinesHan de Gier, University of Groningen, The Netherlands

14:00 – 17:00G 32:CURRENT ISSUES ON DRUG AND HEALTHCARE INFORMATIONFIP Pharmacy Information SectionShort oral presentations will be welcomed to discuss new developments in drug and healthcare information.Learning objectivesThis session aims to:- provide a forum in which FIP members and other interested

parties can expand and share their knowledge about information issues relating to pharmacy, medicines and public health;

- promote networking between various groups that provide information services;

- proactively reach out to enhance the public health and the work of the profession of pharmacy through medicine information programmes and related activities and initiatives.

Chairs: Agathe Wehrli, FIP Pharmacy Information Section, Switzerland and Kevin Moody, FIP Pharmacy Information Section, CanadaSpeakers TBA, based on submission of abstracts

ROOM 90

09:00 – 12:00* G 39:RATIONALISING MEDICATION MANAGEMENT FOR EMERGENCY RESPONSE204 – 999 – 07 – 091 – L04FIP Military & Emergency Pharmacy SectionLearning objectivesAt the conclusion of this session, participants will be able to:- understand the importance of a pharmacist’s

contribution in preparing a package of drugs for donation;

- appreciate the role of the pharmacist in the receiving of drug donations;

- list the important things to consider when donating or receiving drug donations;

- describe the model of Rational Use of Drugs in Chinese Armed Forces;

- understand the basic concept of the Prescription Automatic Screening System (PASS), now being widely used in Chinese Armed Forces;

- understand the process for using new medications in the Uruguay Armed Forces.

14:00 – 17:00* G �0:RESPONDING TO GLOBAL AND LOCAL EMERGENCIES204 – 999 – 07 – 092 – L04FIP Hospital Pharmacy SectionFIP Military and Emergency Pharmacy Section The programme will examine the types of local and global emergencies which can occur, as well as their potential impact on practice. Using ‘real life’ examples, a critical examination of responses to emergency situations will be undertaken in order to allow participants to strengthen their ability create emergency preparedness plans. Participants will have the opportunity to examine the types of aid required during emergencies both locally and abroad, as well as understand the rationale behind current WHO guidelines for donations during emergencies. Learning objectivesAt the conclusion of this session, participants will be able to:- recognise potential emergency situations that

could impact their practice;- understand the impact of emergency situations on

their practice;- understand the key concepts required in order to

formulate an emergency preparedness plan;- critically assess recent responses to emergency

situations in order to identify strategies which have been both successful and unsuccessful;

- use lessons learnt to improve emergency preparedness within their organisation/practice setting;

Chairs: Roger Tredree, St. George’s Hospital, United Kingdom and Jane Dawson, Headquarters New Zealand Defence Force, New Zealand Preparations for biological emergencies Carwen Wynne-Howells, Welsh Assembly Government, United KingdomDonations for emergencies - Help or hindrance Marthe Everard, World Health Organization, SwitzerlandTsunami experience, the reopening of a hospital – Lesson learned from the Australian armed forces Trent Kirk, AustraliaFlu pandemic plan for a peadiatric hospital Régis Vaillancourt, Children’s Hospital of Eastern Ontario, Canada

2�67th INTERNATIONAL CONGRESS OF FIP

SECTION DINNERS

East West Executive Travellers Pte Ltd5, Temasek Boulevard#12-05, Suntec Tower 5, Singapore 038985Tel.: (+65) 6238 8488Fax: (+65) 6238 8878E-mail: [email protected]: www.ewet.comEast West Executive Travellers will handle all reservations for the Section Dinners and the Women in Pharmacy Lunch on Wednesday 5 September 2007.Details and prices will be published on our website www.fip.org/beijing2007 as soon as they become available. For more information, please send an e-mail to [email protected]

FIP YOUNG PHARMACISTS GROUP (YPG)Sunday 2 September 2007EveningYPG Welcome Dinner

Wednesday 5 September 200710:00 – 12:00YPG Business Meeting

INTERNATIONAL PHARMACEUTICAL STUDENTS’ FEDERATION (IPSF)Tuesday 4 September 2007EveningIPSF/YPG International Night

FIP SECTIONS:ACADEMIC PHARMACY SECTIONTuesday 4 September 200712:00 – 14:00AS Business Meeting

Wednesday 5 September 2007EveningAS Dinner

ADMINISTRATIVE PHARMACY SECTIONMonday 4 September 200712:00 – 13:30APS ExCo Meeting

Wednesday 5 September 2007EveningAPS Dinner

Learning objectiveIPS Members and all those interested can learn about new industrial pharmacy developments in general and related to the Industrial Pharmacy Section in particular. EveningIPS Dinner

LABORATORIES AND MEDICINES CONTROL SERVICES SECTIONWednesday 5 September 2007EveningLMCS/CBS Dinner

MILITARY AND EMERGENCY PHARMACY SECTIONWednesday 5 September 2007EveningMEPS Dinner

PHARMACY INFORMATION SECTIONMonday 3 September 200712:00 – 14:00PI Section ExCo Meeting

Wednesday 5 September 200712:00 – 14:00PI Section Business MeetingEveningPI Section Dinner

Thursday 6 September 200708:00 – 09:00PI Section Exco Meeting

PHARMABRIDGEMonday 3 September 200707:30 – 09:00BPP Working Group on Pharmabridge Meeting

Tuesday 4 September 200717:00 – 18:00PHARMABRIDGE MEETINGPharmabridge aims at strengthening pharmaceutical services in developing (DC) and transitional countries through coordinated support from the pharmacy establishment and individual pharmacists in developed countries. The project even goes beyond this: It also aims at creating links amongst pharmacists worldwide and is supported by the International Pharmaceutical Federation (FIP), its Board of Pharmaceutical Practice (BPP) and the Commonwealth Pharmaceutical Association (CPA). All those interested in the project, be it from developing or developed countries, wanting to establish contacts with colleagues from other countries (or even a specific country) are invited to attend this meeting.

Thursday 6 September 200712:00 – 13:30APS Business Meeting

CLINICAL BIOLOGY SECTIONMonday 3 September 200708:45 – 12:00Clinical Laboratory Medicine visits

Wednesday 5 September 2007EveningCBS/LMCS Dinner

COMMUNITY PHARMACY SECTIONFriday 31 August 200709:00 – 17:00CPS ExCo Meeting

Wednesday 5 September 2007EveningCPS Dinner

Friday 7 September 200709:00 – 12:00CPS ExCo Meeting

HOSPITAL PHARMACY SECTION Sunday 2 September 200718:00 – 10:00HPS Welcome Reception

Monday 3 September 200709:00 – 12:00HPS Officers Meeting (1)

Tuesday 4 September 200713:00 – 13:45HPS Business Meeting14:30 – 17:00HPS Officers Meeting (2)

Wednesday 5 September 2007Evening HPS Dinner

INDUSTRIAL PHARMACY SECTIONWednesday 5 September 200712:00 – 14:00IPS Business Meeting: INDUSTRIAL PHARMACY SCIENCE & PRACTICEThe FIP Industrial Pharmacy Section describes the scientific and practice changes that effect the industrial environment, presents the IPS Medal winner for industrial pharmaceutical excellence, the IPS Mike How Award winner for young pharmacists/pharmaceutical students, and explains about future IPS activities.

ADDITIONAL PROGRAMME ITEMS


CALL FOR ABSTRACTSand paid as Congress participants will be cancelled; these abstracts can not be presented and will not be published.

- For some topics the presenting author is invited to indicate a preference for oral or poster presentation. However, the screening officers will make the final decision based on the suitability of the abstracts and availability of space.

ABSTRACT CONFIRMATION LETTERS The corresponding author will be informed about the review outcome by e-mail.

Abstract submitted before 1 March 2007: Confirmation e-mail before 21 March 2007.

Abstract submitted between 1 March and 1 April 2007: Confirmation e-mail before 21 April 2007.

After 1 May 2007 the corresponding author will be informed by e-mail that the abstract is cancelled if the author has not registered and/or paid for the Congress.

POSTERSAll posters will be on display during all days of the Congress.Monday 3 to Wednesday 5 September 2007, from 09:00 – 16:00Thursday 6 September 2007 from 09:00 to 14:00.Presenters should be at their poster board between 12:00 and 14:00 every day.Posters may be put up on Sunday 2 September 2007 from 09:00 to 16:00.Posters must be removed on Thursday 6 September 2007 before 16:00.The size of the poster boards will be published on our website www.fip.org/beijing2007 as soon as it becomes available.

Please note: NOT APPLICABLE FOR INVITED (SECTION) SPEAKERS.Separate information will be sent to you by FIP.

ABSTRACT HANDLINGAbstract handling will be carried out by:NewBrooklynP.O. Box 733620 AB BreukelenThe NetherlandsTel.: (+31) (0)346 266 110E-mail: [email protected]

ABSTRACT SUBMISSION AND DEADLINES Abstracts need to be submitted online via the website abstract form before Sunday 1 April 2007. Please visit our website: www.fip.org/beijing2007/abstracts.

IMPORTANT- The maximum length of the abstract is 375 words, excluding

the title, and excluding the name(s) and affiliations of the authors and co-authors.

- If the author does not receive an automatically generated e-mail confirming the submission of the abstract, the abstract is NOT SUBMITTED. The abstract author needs to return to the abstract form and finalise the abstract submission procedure before 1 April 2007.

- Abstracts will only be accepted for presentation and publication in the Abstract Book if the presenting author has registered and paid for the Congress before 1 May 2007. After 1 May 2007 the abstracts of presenting authors not registered

TOPICSAbstracts can only be submitted on one of following topics: Pharmaceutical Practice Screening OfficerAcademic Pharmacy Ronnie HanssonAdministrative Pharmacy Marion SchaeferClinical Biology Bernard PoggiCommunity Pharmacy: Kurt Fonnesbaek Rasmussen 1. Innovative ways of collaboration between community pharmacists and GP’s 2. Experiences with patient profiles 3. Counterfeit medicines 4. The role of the pharmacist in public health 5. OtherHospital Pharmacy Rebekah MolesIndustrial Pharmacy Erich Sturzenegger and Adel SakrLaboratory and Medicines Control Services Frans van de VaartMilitary & Emergency Pharmacy Régis VaillancourtPharmacy Information Han de GierHistory of Pharmacy Jacques Gravé

Special Interest Groups Bioavailability/Bioequivalence Vinod ShahBiopharmaceutics Classification System Dirk Maarten Barends and James PolliDissolution/In Vitro Release Performance Testing Horst-Dieter Friedel and Cynthia BrownNatural Substances Toshio Honda and Carmen TamayoIndividualised Medicine Hitoshi Sasaki and Anke-Hilse Maitland-van der ZeeNuclear/Radiologic Pharmacy Clyde Cole and Eduardo SavioPharmaceutical Biotechnology Gavin Brooks and Hideyoshi Harashima Pharmacoepidemiology/Pharmacoeconomics Bert Leufkens and Brenda Waning


GENERAL INFORMATIONAVIATIONThe Beijing International Airport is a gateway to nearly 100 international destinations. About 40 international airlines have offices in Beijing. Passengers on departure are charged airport construction fee: 50 Yuan (app. 5 Euro) for domestic travellers and 90 Yuan (app. 9 Euro) for international travellers. This will be charged upon departure. Taxi fare from the airport to downtown Beijing is about 100 Yuan (app. 10 Euro). A car ride between the airport and downtown Beijing takes between 30 minutes and 1 hour, depending on traffic. Shuttle service will also be provided.

BADGESParticipants will be handed their name badges at the registration desk. Due to tight security regulations all participants and accompanying persons must wear their badges throughout the Congress. Participants with white badges will be admitted to the sessions. Accompanying persons (badges in a different color) may attend the Opening Ceremony, social events and tours but will not be allowed to attend sessions.

BARGAININGBargaining does not work in most department stores, shopping malls and gift shops in hotels but is broadly acceptable in open-air markets, antique markets, with street vendors and other privately owned shops that sell garments, souvenirs and handicrafts.

CLIMATEDetailed information about the average temperatures and the rainfall in Beijing.

Average Data Aug Sep Oct

Average High ( F) 84 77 66Average High ( C) 29 25 19

Average Low ( F) 67 56 43Average Low ( C) 20 13 6

Rain (in) 7.1 <0.1 0.6Rain (mm) 180 <5 15

CREDIT CARDS, TRAVELLER’S CHEqUES Most airlines, hotels, up-scale restaurants, bars and department stores take credit cards but we recommend that you have a certain amount of cash in local currency. Traveller’s cheques issued by major overseas banks may be exchanged at the Bank of China and CITIC Bank branches as well as authorised currency exchange counters.

CURRENCYRenmibi (RMB) is the sole legal currency in China. The basic currency unit is Yuan. One Yuan equals 10 jiao or 100 fens. There are 8 paper notes: 100 Yuan, 50 Yuan, 20 Yuan, 10 Yuan, 5 Yuan, 2 Yuan and 1 Yuan. The largest RMB coin is 1 Yuan. 100 Yuan = appr. 12 US$ and 10 Euro. Change money at Banks or Hotels but never on the street. It is illegal and you can be robbed.

DRESSInformal dress is acceptable for all sessions but business attire

is recommended for the Opening Ceremony. For the Goodbye Dinner Party we advise informal dress.

ELECTRICITY VOLTAGEElectric supply in China is 220 volts. Hotels usually have adapters available.

EXHIBITIONThe exhibition is the responsibility of and organised by the Chinese Pharmaceutical Association.All Chinese and international pharmaceutical companies are invited to contact the Chinese Pharmaceutical Association. For more information please send an e-mail to: [email protected]

INTERNETInternet access is available in guest rooms of five-star hotels and most four-star hotels as well as in all business centres of star-rated hotels. There are Internet cafes in the city of Beijing, where local direction is necessary. Some hotels will charge for this individually.

INSURANCEThe FIP Organising Committee and the Chinese Host Committee accept no liability for personal injuries, or for loss of or damage to property belonging to Congress participants and/or accompanying persons, incurred either during or as a result of the Congress. We recommend that each participant acquires personal insurance.

LANGUAGEMandarin is the official language in the Chinese capital and is understood by most educated Chinese. Young Chinese also speak more and more English. In most hotels staff at the reception area and the business centre speak English.

PASSPORTCarry your passport with you at all times. You need it when changing money and could be asked when you pay by credit card. In case you loose your passport, you should immediately contact the embassy of your country and report the loss to the Public Security Bureau.

POSTAL SERVICEMost hotels provide postal service and sell stamps. Post offices, with the green logo of China Postal are open from 9.00 am until 7.00 pm.

PRESS ROOMThe Congress Press Room will offer a number of services, strictly limited for official press representatives and professional journalists. They will have access to written press material (press releases, speakers’ presentations, etc.) and to working facilities as well as a chance to socialise with their colleagues. There will also be a series of media briefings highlighting prominent topics. Press accreditation and Press registration are required to have access to the Congress Press Room. For more information, please contact FIP at [email protected]. SPEAKERS’ PREVIEW ROOMPowerPoint presentations may be tested, updated and copied for back up in the speakers’ preview room before presentations. The


speakers’ preview room will offer working facilities to invited Speakers and Chairs as well as a chance to socialise with their colleagues.

TECHNICAL EqUIPMENT IN SESSION ROOMSAll session rooms will have LCD projectors and laptops. There will be a technician available in every session room.

TELEPHONE CALLSWith regard to calls from China, we can inform you that for direct calls using handphones, the cost is approximately Euro 0.85/min. Most people buy calling cards which provide up to 70% discounts from the direct call rates. These cards can be purchased at the airports or in many places in the city. Rates when using these cards range from Euro 0.35 – 0.68/min., depending on where the call is going to as different cities have different rates. TIPPINGTipping is not generally practiced in China and is discouraged by the authorities. In many hotels and restaurants, the staff is not allowed by the management to take tips. Exceptions are tour guides and drivers who are with you all day, and bellboys who are very helpful at hotels. In most cases you should give between 10-20 Yuan (app. 1-2 Euro).

TRANSPORTATIONBeijing’s Subway is the oldest in China and goes along the most historic and cultural heritages in downtown Beijing. The interval between two trains is approximately 5 minutes, and 2 to 3 minutes in rush hours; the subway runs between 5.00 am and 11.00 pm. A ticket costs about 3 Yuan.Taxi is the easiest way to travel around Beijing. Drivers are required to turn on their meter and give a receipt. They are not allowed to turn down any rides. As taxi drivers in general speak very little English it is advisable to carry a note with your destination written in Chinese characters. Prices vary from 1.2 Yuan for a medium car to 2 Yuan for luxury cars.

Tourist visa can be obtained at Chinese embassies and consulates worldwide. Visa are usually valid during three months with a maximum stay of 30 days in China. Please ask the Chinese Embassy or Consulate in your country whether or not you need a visa and, if you do, what you should do and how long this procedure will take. You can apply for an official invitation letter from the Chinese Pharmaceutical Association (please see: Letter of Invitation). In order to avoid disappointment we advise you to start your visa application procedure no later than 1 May 2007.

LETTER OF INVITATIONPlease check which option (A or B) is applicable for you and follow these instructions.You cannot request an official invitation letter in any other way.If your accompanying person(s) need(s) an individual invitation letter (apart from yours) it is required to make a separate visa application via option A.

Option AYou are not certain that you will be issued a visa and, therefore, do not want to risk paying the registration fee before you have been issued a visa. (This option will be closed on 1 July 2007.)The procedure is as follows:- The official invitation letter can only be obtained via the

special FIP – Letter of Invitation Form on www.fip.org/beijing2007;- Payment of the administration fee of €50 is required online by

credit card. No other payment option is available.- The official invitation letter will be sent by e-mail to the

address provided. The letter will not be sent by post or by fax. The letter will not be sent to Embassies or Consulates;

- The amount of €50 will only be refunded to registered Congress participants. These registered and paid-up Congress participants will receive the refund on-site during the Congress.

Option BYou are certain a visa will be issued to you and, therefore, you would like to register as soon as possible in order to qualify for the early fee.You can follow this procedure to obtain a letter of invitation:- Register as a Congress participant via www.fip.org/beijing2007;- Pay the full registration fee;- All congress participants (registered and paid) will receive

both a confirmation letter and (until 1 July 2007) a letter of invitation;

- The letters will be sent by e-mail to the address provided. The letters will not be sent by post or by fax. The letters will

not be sent to Embassies or Consulates.

CancellationThe terms of cancellation (see page 32) will apply even if your reason for cancelling is that you cannot obtain a visa.

VISA APPLICATION


REGISTRATION PROCESS

Chinese delegates!All Chinese registrations will be handled by theChinese Pharmaceutical Association (CPA)Tel.: (+86) 10 58699271Fax: (+86) 10 58699272E-mail: [email protected]

Congress registration for all other participants is handled by NewBrooklynand can only be made through the website:http://www.fip.org/beijing2007/registration

Please direct all registration and/or payment inquiries to NewBrooklyn at:Tel.: (+31) 346 266 110Fax: (+31) 346 263 308E-mail: [email protected]

Individual registrationIndividual delegates can register (and pay) directly via http://www.fip.org/beijing2007/registration

Presenting abstract authors If you are the presenting author of an abstract you have to register online for the congress and pay before 1 May 2007. On the online congress registration form presenting authors can choose to register as:* FIP member – presenting author* FIP non member – presenting author* Student - presenting authorThe abstract internet number is required on the congress registration form.If you have not registered, paid and mentioned the abstract internet number on your registration form, your abstract will NOT be accepted.

Free of fee registration Free of fee registration is only possible, if you have received a required code from the person who has invited you. We kindly ask you to register via the online registration form as soon as you have received this required code. This code helps NewBrooklyn to process your free registration. Should you not have received this required code, please do NOT contact NewBrooklyn, but the person by whom you were invited.

Group registrationGroup registration is possible only if the following three conditions are met:* The invoice for all group members can be sent to one

invoice address.* The group has a contact person who is responsible for

registration and payment.* The group includes a minimum of 5 participants.

To register a group, please follow the instructions on the website: http://www.fip.org/beijing2007/groupregistration

Payment If you register you can pay:* Online by credit card via a secured site. * By bank transfer after receipt of an invoice.

In order to expedite the registration process, we advise you to fill in the online registration form and use your credit card for online payment via a secured site. Please note: as soon as you have submitted your online registration form, we can no longer charge your credit card due to extra safety.

In order to pay by bank transfer, you will first require an invoice. An invoice will be sent to you by e-mail. The invoice provides the FIP registration bank account details for transfer purposes. Please do not transfer fees until you have received your invoice. It is essential that you include your invoice number when instructing your bank. The congress secretariat will not be responsible for identifying funds transferred directly into the FIP (registration) account.

Confirmation of registration* After submitting your online registration form, you should

immediately receive an automatically generated e-mail acknowledging submission of your registration. - If you do not receive this automatic generated e-mail, your form is NOT submitted: - Please return to your form and finalise the online-registration process by SUBMITTING your form.

* Once NewBrooklyn has administered your registration, you will receive an invoice/proof of payment by e-mail.

* After receipt of your payment, you will receive a confirmation of registration and (until 1 July 2007) a letter of invitation.

Confirmation of tours and section dinners will be handled by East West Executive Travellers. E-mail: [email protected]

HOW TO REGISTER


The registration fee for participants includes* Admission to all sessions

except the pre-satellite symposia, and the Satellite Continuing Education Programme for which additional registration (fee) before 1 August is required.

* Opening Ceremony on Sunday 2 September* Welcome Reception on Monday 3 September* Entrance to the Exhibition* Congress Bag with

- Final Congress Programme- Abstract Book- List of Participants (name and country of participants

registered and paid by 15 July 2007)

Please note that the fee for accompanying persons does NOT include admission to the sessions.

Registration fees please check the registration Payment until Payment until Payment afterqualifications very carefully 1 May 2007 1 August 2007 1 August 2007 and on site

FIP Individual member € 575 € 675 € 975

FIP Individual member and presenting abstract author € 575

Non-member € 825 € 925 € 975

Non-member and presenting abstract author € 825

Student/Recent graduate € 200 € 250 € 300

Student/Recent graduate and presenting abstract author € 200

On site day card can only be purchased on site € 300

Pre-satellite symposium R1Industrial Pharmacy Section: Fri & Sat € 200 € 200

Pre-satellite symposium R2Pharmacy Information Secion:Fri & Sat € 200 € 200

Pre-satellite symposium R3Community Pharmacy Section:Sat € 100 € 100

Pre-satellite symposium R4Community Pharmacy Section: Sat & Sun € 100 € 100

Satellite Continuing Education Programme Community Pharmacy Section:Thu € 100 € 100 € 100

Accompanying person € 150 € 150 € 150

Goodbye Dinner Party € 120 € 120 € 120

On-site you will receive (if applicable for you) * Hard copy of your proof of payment* Certificate of attendance* Poster/oral certificate (if applicable)

The registration fee for accompanying persons includes* Opening Ceremony on Sunday 2 September* Welcome Reception on Monday 3 September* Entrance to the Exhibition* Option to book tours * Option to purchase tickets for social events

REGISTRATION FEES


REGISTRATION qUALIFICATIONS

FIP memberIn order to qualify for FIP member registration fee, three conditions must be met:* You must be an individual member of FIP, at least in 2006 &

2007.* Your FIP membership fee for 2007 must have been paid

before 1 April 2007.* Your FIP membership number must be filled in on the

(online) registration form.

Student/Recent graduateIn order to qualify for Student/Recent graduate fee, two conditions must be met.* You must still be a student or have graduated from your last

study after September 2002. * You must attach to your online registration form an official

document signed by the Head of Department of your university proving your Student/Recent graduate status.

* Until the congress registration office has received your proof of student status the registration fee for FIP non-member will be applicable.

Council delegateIn order to qualify for Council delegate registration fee you must attach to your online registration form a proof that you have been officially appointed by your organisation to represent your organisation at the Council meeting. Until the congress registration office has received this proof the registration fee for FIP non-member will be applicable.

Press In order to qualify for Press registration you must attach your press accreditation to the online registration form.

Day cardsDay cards can only be purchased on site. Pre-registration for a day card is not possible. Please note: it is not possible to exchange a pre-registration booking into a day card.

Pre-satellite symposiaRegistration for one of the pre-satellite symposia is only possible in addition to registration for the full conference. If you wish to attend one of the pre-satellites you need to book before 1 August 2007.

Satellite Continuing Education Programme For the Satellite Continuing Education Programme you can either pre-register or book on-site.

Goodbye Dinner Party at the Great WallThe Goodbye Dinner Party is being held on Thursday 6 September and requires additional registration via the website congress registration form together with your registration for the congress. The number of seats is limited, therefore if you would like to attend the Goodbye Dinner Party we advise you to order tickets in advance.

TERMS OF CANCELLATIONNotification of cancellation must be made in writing and sent to NewBrooklyn. * In case of cancellation before 1 May 2007, the registration

fee less an administration fee of 10% will be refunded.* In case of cancellation between 1 May and (before!) 1

August 2007, the registration fee less an administration fee of 50% will be refunded.

* As of 1 August 2007, the registration fee will not be refunded.

Please note that the terms of cancellation are applicable in all circumstances, also if a visa is officially refused to the participant.

ON SITE REGISTRATIONIf you register or pay on site the on site fee is applicable.Day cards can only be purchased on site.On site payment of registration fees can be made: * Online with credit card: VISA, MasterCard or American

Express are accepted. Due to extra security, the credit card companies ask for your SecureCode (MasterCard) or password (Visa) in order proceed your payment. Please make sure you know your SecureCode or password!

* Cash in Euro or US Dollar.

CERTIFICATE OF ATTENDANCE If you would like to receive a Certificate of Attendance please make sure you collect your certificate during the congress at the on-site registration desk before 12:00 on Thursday 6 September 2007. Certificates will NOT be sent after the congress!

ABSTRACT CERTIFICATEIf you would like to receive a poster or oral certificate please make sure you collect this certificate during the congress at the on-site registration desk before 12:00 on Thursday 6 September 2007. Certificates will NOT be sent after the congress!

REGISTRATION DESKThe registration desk will be open:* Friday 31 August 2007 from 08:00 to 09:30, ONLY for

participants attending one of the Pre-satellite meetings.* Saturday 1 September to Thursday 6 September 2007 from

08:30 – 17:30.

Lay-out Jos Lammers, The Hague, The Netherlands Printing Kooiman Drukwerk, Barendrecht, The Netherlands

HOW TO REGISTER


preliminary programme - fip...beijing 102211 china tel.: (+86) 10 61782288 fax:fax: (+86) 10...

Documents